ライフサイエンス / 腫瘍診断、治療学

ライフサイエンス / 腫瘍生物学

日本生化学会

米国糖鎖生物学会

米国泌尿器科学会

日本生化学会

日本泌尿器腫瘍学会

日本泌尿器科学会

Treatment patterns and prognosis in patients with Bacillus Calmette-Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysis.

Nishimura N, Miyake M, Iida K, Miyamoto T, Tomida R, Numakura K, Inokuchi J, Yoneyama T, Okajima E, Yajima S, Masuda H, Terada N, Taoka R, Kobayashi T, Kojima T, Matsui Y, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K

World journal of urology   42 ( 1 )   185   2024年03月

Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study.

Fujita N, Hatakeyama S, Tabata R, Okita K, Kido K, Hamano I, Tanaka T, Noro D, Tokui N, Suzuki Y, Yoneyama T, Hashimoto Y, Sato S, Ohyama C

Prostate international   12 ( 1 )   46 - 51   2024年03月

The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin therapy.

Kikuchi H, Abe T, Miyake M, Miyata H, Matsumoto R, Osawa T, Nishimura N, Fujimoto K, Inokuchi J, Yoneyama T, Tomida R, Numakura K, Matsushita Y, Matsumoto K, Sato T, Taoka R, Kobayashi T, Kojima T, Matsui Y, Nishiyama N, Kitamura H, Nishiyama H, Shinohara N

Japanese journal of clinical oncology   54 ( 2 )   192 - 200   2023年11月

Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab.

Hamaya T, Hatakeyama S, Yoneyama T, Tobisawa Y, Kodama H, Fujita T, Murakami R, Mori K, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Saitoh H, Narumi S, Tomita H, Ohyama C

Scientific reports   13 ( 1 )   15098 - 15098   2023年09月

Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: A multicenter retrospective study.

Okuyama Y, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka T, Fujita N, Okamoto T, Mori K, Yamamoto H, Yoneyama T, Hashimoto Y, Matsuoka T, Sato S, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   30 ( 8 )   649 - 657   2023年05月

Summary of the clinical practice manual for late-onset hypogonadism.

Ide H, Akehi Y, Fukuhara S, Ohira S, Ogawa S, Kataoka T, Kumagai H, Kobayashi K, Komiya A, Shigehara K, Syuto T, Soh J, Tanabe M, Taniguchi H, Chiba K, Matsushita K, Mitsui Y, Yoneyama T, Shirakawa T, Fujii Y, Kumano H, Ueshiba H, Amano T, Sasaki H, Maeda S, Mizokami A, Suzuki K, Horie S

International journal of urology : official journal of the Japanese Urological Association   30 ( 5 )   422 - 430   2023年05月

Relationship between lower urinary tract symptoms and frailty.

Ozaki Y, Hatakeyama S, Imai A, Songee J, Soma O, Ozaki K, Fujita N, Okamoto T, Iwamura H, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   30 ( 7 )   606 - 613   2023年04月

Subsequent Upper Urinary Tract Carcinoma Related to Worse Survival in Patients Treated with BCG.

Numakura K, Miyake M, Kobayashi M, Muto Y, Sekine Y, Nishimura N, Iida K, Shiga M, Morizane S, Yoneyama T, Matsumura Y, Abe T, Yamada T, Matsumoto K, Inokuchi J, Nishiyama N, Taoka R, Kobayashi T, Kojima T, Kitamura H, Nishiyama H, Fujimoto K, Habuchi T

Cancers   15 ( 7 )   2023年03月

Trends in the age of hospitalized patients with urological cancers: A 17-year experience.

Ishii N, Hatakeyama S, Miura H, Tanaka R, Oishi T, Horiguchi H, Hosogoe S, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   30 ( 7 )   572 - 578   2023年03月

Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy.

Oishi T, Hatakeyama S, Tabata R, Fujimori D, Fukuda M, Shinozaki T, Ishii N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C

Scientific reports   13 ( 1 )   3436   2023年03月

Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study.

Ozaki Y, Narita T, Hatakeyama S, Tanaka T, Togashi K, Hamaya T, Ozaki K, Ishi N, Oishi T, Tokui N, Mikami J, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Translational andrology and urology   12 ( 2 )   161 - 167   2023年02月

Combination of Muscle Quantity and Quality Is Useful to Assess the Necessity of Surveillance after a 5-Year Cancer-Free Period in Patients Who Undergo Radical Cystectomy: A Multi-Institutional Retrospective Study.

Fujita N, Momota M, Horiguchi H, Hamano I, Mikami J, Hatakeyama S, Ito H, Yoneyama T, Hashimoto Y, Nishimura S, Yoshikawa K, Ohyama C

Cancers   15 ( 5 )   2023年02月

Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study.

Oishi T, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka R, Ishii N, Miura H, Tanaka T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C

The Prostate   83 ( 2 )   198 - 203   2023年02月

Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer.

Fujita N, Hatakeyama S, Okita K, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

PloS one   18 ( 2 )   e0275921   2023年02月

腎結石形成に関与する糖鎖変異オステオポンチンの探索

阿南 剛, 米山 徹, 廣瀬 卓男, 畠山 真吾, 森 建文, 大山 力, 佐藤 信

日本尿路結石症学会誌   21 ( 2 )   64 - 65   2023年02月

Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study.

Fujita N, Momota M, Ozaki Y, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

The world journal of men's health   41 ( 4 )   900 - 908   2023年01月

Association between Advanced Glycation End-Products, Carotenoids, and Severe Erectile Dysfunction.

Fujita N, Ishida M, Iwane T, Suganuma H, Matsumoto M, Hatakeyama S, Yoneyama T, Hashimoto Y, Mikami T, Itoh K, Ohyama C

The world journal of men's health   41 ( 3 )   701 - 711   2023年01月

Aberrant glycosylation of osteopontin in a rat renal stone formation model: A preliminary study.

Anan G, Yoneyama T, Hirose T, Sato M, Mori T, Ohyama C

BJUI compass   4 ( 1 )   63 - 65   2023年01月

イムノグロブリン<i>N</i>型糖鎖プロファイルを基盤とした機械学習アプローチによる腎移植後の拒絶予測モデルの開発

小玉 寛健, 米山 徹, 岩村 大径, 藤田 尚紀, 田中 壽和, 畠山 真吾, 柿崎 育子, 大山 力

移植   58 ( Supplement )   s226_2 - s226_2   2023年

Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers.

Togashi K, Hatakeyama S, Soma O, Okita K, Fujita N, Tanaka T, Noro D, Horiguchi H, Uemura N, Iwane T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Cancers   14 ( 24 )   2022年12月

Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study.

Ozaki K, Hatakeyama S, Narita S, Hata K, Yanagisawa T, Tanaka T, Togashi K, Hamaya T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Kimura T, Habuchi T, Ohyama C

World journal of urology   41 ( 1 )   67 - 75   2022年12月

Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction.

Miura H, Hatakeyama S, Tanaka T, Fujita N, Horiguchi H, Tanaka R, Noro D, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   41 ( 5 )   254.e17 - 254.e24   2022年12月

Associations of impaired grip strength and gait function with the severity of erectile dysfunction in men undergoing dialysis: a cross-sectional study.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

The aging male : the official journal of the International Society for the Study of the Aging Male   25 ( 1 )   1 - 7   2022年12月

Association of oxidative stress with erectile dysfunction in community-dwelling men and men on dialysis.

Fujita N, Momota M, Ishida M, Iwane T, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoshikawa K, Yamaya K, Ohyama C

The aging male : the official journal of the International Society for the Study of the Aging Male   25 ( 1 )   193 - 201   2022年12月

Relationships of low-grade systemic inflammation and nutritional status with erectile dysfunction severity in men on dialysis.

Fujita N, Hatakeyama S, Momota M, Hamaya T, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Andrology   10 ( 8 )   1548 - 1555   2022年11月

Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids.

Ishii N, Hatakeyama S, Yoneyama T, Tanaka R, Narita T, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   40 ( 10 )   451.e1 - 451.e8   2022年10月

Proportion of patients eligible for adjuvant immunotherapy in nonmetastatic clear-cell renal cell carcinoma treated with radical or partial nephrectomy.

Tanaka R, Hatakeyama S, Miura H, Hamaya T, Yoneyama T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   29 ( 10 )   1235 - 1237   2022年10月

Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Scientific reports   12 ( 1 )   13786 - 13786   2022年08月

Selective reaction monitoring approach using structure-defined synthetic glycopeptides for validating glycopeptide biomarkers pre-determined by bottom-up glycoproteomics.

Shiratori K, Yokoi Y, Wakui H, Hirane N, Otaki M, Hinou H, Yoneyama T, Hatakeyama S, Kimura S, Ohyama C, Nishimura SI

RSC advances   12 ( 33 )   21385 - 21393   2022年07月

Impact of body size on skin-related adverse events in advanced prostate cancer treated with apalutamide: A multicenter retrospective study.

Sasaki D, Hatakeyama S, Tanaka T, Okamoto T, Yoneyama T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   29 ( 7 )   772 - 773   2022年07月

Kidney Transplantation in a Patient With Noonan Syndrome: A Case Report.

Kodama H, Hatakeyama S, Hamaya T, Murakami R, Murasawa H, Yamamoto H, Yoneyama T, Ohyama C

Transplantation proceedings   54 ( 6 )   1601 - 1603   2022年07月

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy.

Iwamura H, Hatakeyama S, Narita T, Ozaki Y, Konishi S, Horiguchi H, Kodama H, Kojima Y, Fujita N, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Scientific reports   12 ( 1 )   9675 - 9675   2022年06月

Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

The world journal of men's health   41 ( 2 )   373 - 381   2022年05月

Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guérin therapy.

Fujita N, Hatakeyama S, Momota M, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   29 ( 8 )   867 - 875   2022年05月

Machine learning diagnosis by immunoglobulin N-glycan signature for precision diagnosis of urological diseases.

Iwamura H, Mizuno K, Akamatsu S, Hatakeyama S, Tobisawa Y, Narita S, Narita T, Yamashita S, Kawamura S, Sakurai T, Fujita N, Kodama H, Noro D, Kakizaki I, Nakaji S, Itoh K, Tsuchiya N, Ito A, Habuchi T, Ohyama C, Yoneyama T

Cancer science   113 ( 7 )   2434 - 2445   2022年05月

Renal metastasis of ovarian granulosa cell tumor.

Togashi K, Yoneyama T, Sutoh Yoneyama M, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Futagami M, Ohyama C

IJU case reports   5 ( 3 )   186 - 190   2022年05月

Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study.

Tanaka T, Hatakeyama S, Noro D, Togashi K, Yoneyama T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   29 ( 5 )   476 - 478   2022年05月

TMEM2 expression is downregulated as bladder cancer invades the muscle layer.

Yoneyama MS, Yoneyama T, Tobisawa Y, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Suzuki T, Ohyama C

Biochemical and biophysical research communications   613   1 - 6   2022年04月

Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients.

Hamaya T, Hatakeyama S, Yoneyama T, Tobisawa Y, Kodama H, Fujita T, Murakami R, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Saitoh H, Narumi S, Tomita H, Ohyama C

Scientific reports   12 ( 1 )   5876 - 5876   2022年04月

Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma.

Togashi K, Hatakeyama S, Yoneyama T, Hamaya T, Narita T, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   29 ( 7 )   733 - 739   2022年03月

Effect of advanced glycation end products on nocturia or sleep disorders: A longitudinal study.

Konishi S, Hatakeyama S, Imai A, Okita K, Kido K, Ozaki Y, Uemura N, Iwane T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

BJUI compass   3 ( 2 )   162 - 168   2022年03月

The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma.

Ozaki K, Hatakeyama S, Tanaka T, Noro D, Tokui N, Horiguchi H, Okuyama Y, Fujita N, Okamoto T, Okamoto A, Suzuki Y, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

BJUI compass   3 ( 2 )   139 - 145   2022年03月

Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomy.

Nishimura N, Miyake M, Iida K, Miyamoto T, Tomida R, Numakura K, Inokuchi J, Yoneyama T, Matsumura Y, Yajima S, Masuda H, Terada N, Taoka R, Kobayashi T, Kojima T, Matsui Y, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K

International journal of urology : official journal of the Japanese Urological Association   29 ( 3 )   242 - 249   2022年03月

Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma.

Okuyama Y, Hatakeyama S, Numakura K, Narita T, Tanaka T, Miura Y, Sasaki D, Noro D, Tokui N, Okamoto T, Yamamoto H, Narita S, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama C

BJUI compass   3 ( 2 )   154 - 161   2022年03月

Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer.

Miura Y, Hatakeyama S, Tanaka T, Fujita N, Horiguchi H, Okuyama Y, Kojima Y, Noro D, Tokui N, Okamoto T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Ohyama C

BJUI compass   3 ( 2 )   146 - 153   2022年03月

Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study.

Sasaki D, Hatakeyama S, Kawaguchi H, Hatayama Y, Ishibashi Y, Kusaka A, Noro D, Tanaka T, Ito H, Okuyama Y, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Aoki M, Ohyama C

Urologic oncology   40 ( 2 )   64.e1 - 64.e8   2022年02月

フレイルと合併症は限局性前立腺癌の治療選択に関与する因子である

小玉 寛健, 畠山 真吾, 岡本 哲平, 米山 徹, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力

日本泌尿器科学会総会   109回   PP33 - 04   2021年12月

イムノグロブリンN-glycan signatureによる尿路上皮癌の診断法

小玉 寛健, 米山 徹, 田中 壽和, 野呂 大輔, 飛澤 悠葵, 山本 勇人, 須藤 晋一郎, 畠山 真吾, 米山 高弘, 橋本 安弘, 柿崎 育子, 中路 重之, 大山 力

日本泌尿器科学会総会   109回   AOP07 - 01   2021年12月

臨床的に重要な前立腺癌の検出のための血清でのPSAの2,3-結合シアリル化とコア型フコシル化の同時分析

波多野浩士, 米山徹, 畠山真吾, 藤田和利, 藤田和利, 三善英知, 吉村一宏, 植村天受, 大山力, 野々村祝夫

日本泌尿器科学会総会(Web)   109回   ISP02 - 03   2021年12月

Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer.

Hatano K, Yoneyama T, Hatakeyama S, Tomiyama E, Tsuchiya M, Nishimoto M, Yoshimura K, Miyoshi E, Uemura H, Ohyama C, Nonomura N, Fujita K

British journal of cancer   126 ( 5 )   764 - 770   2021年11月

Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries.

Konishi S, Narita T, Hatakeyama S, Yoneyama T, Yoneyama MS, Tobisawa Y, Noro D, Sato T, Togashi K, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Scientific reports   11 ( 1 )   22103 - 22103   2021年11月

血清イムノグロブリンN-glycan signatureによる尿路上皮癌の診断法

小玉寛健, 米山徹, 田中壽和, 野呂大輔, 須藤晋一郎, 飛澤悠葵, 山本勇人, 畠山真吾, 米山高弘, 橋本安弘, 柿崎育子, 中路重之, 大山力

日本癌治療学会学術集会(Web)   59回   O18 - 3   2021年10月

高リスク上部尿路上皮癌への術前化学療法と腫瘍学的転帰の傾向:多施設後ろ向き研究

濱谷智子, 畠山真吾, 田中壽和, 久保田優花, 富樫赳, 細越正吾, 藤田尚紀, 日下歩, 得居範子, 岡本哲平, 山本勇人, 米山徹, 米山高弘, 橋本安弘, 大山力

日本癌治療学会学術集会(Web)   59回   O22 - 1   2021年10月

Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level.

Yoneyama T, Yamamoto H, Sutoh Yoneyama M, Tobisawa Y, Hatakeyama S, Narita T, Kodama H, Momota M, Ito H, Narita S, Tsushima F, Mitsuzuka K, Yoneyama T, Hashimoto Y, Duivenvoorden W, Pinthus JH, Kakeda S, Ito A, Tsuchiya N, Habuchi T, Ohyama C

The Prostate   81 ( 16 )   1411 - 1427   2021年09月

Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study.

Narita T, Hatakeyama S, Numakura K, Kobayashi M, Muto Y, Saito M, Narita S, Tanaka T, Noro D, Tokui N, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   28 ( 9 )   899 - 905   2021年09月

腎臓結石形成に関与する糖鎖変異オステオポンチンの同定

阿南 剛, 米山 徹, 畠山 真吾, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力

日本腎臓学会誌   63 ( 4 )   447 - 447   2021年06月

The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma.

Okita K, Hatakeyama S, Hagiwara K, Suzuki Y, Tanaka T, Noro D, Tokui N, Fujita N, Konishi S, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   39 ( 12 )   832.e17 - 832.e23   2021年04月

Narrative review of urinary glycan biomarkers in prostate cancer.

Hatakeyama S, Yoneyama T, Tobisawa Y, Yamamoto H, Ohyama C

Translational andrology and urology   10 ( 4 )   1850 - 1864   2021年04月

Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.

Horiguchi H, Hatakeyama S, Yoneyama T, Yoneyama MS, Tanaka T, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Yoshizawa T, Hashimoto Y, Kawaguchi T, Ohyama C

Urologic oncology   39 ( 4 )   238.e9-238.e17 - 238.e17   2021年04月

Non-maintenance intravesical Bacillus Calmette-Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study.

Miyake M, Iida K, Nishimura N, Miyamoto T, Fujimoto K, Tomida R, Matsumoto K, Numakura K, Inokuchi J, Morizane S, Yoneyama T, Matsumura Y, Abe T, Inoue M, Yamada T, Terada N, Hirao S, Uemura M, Matsushita Y, Taoka R, Kobayashi T, Kojima T, Matsui Y, Kitamura H, Nishiyama H, Japanese Urological Oncology Group

BMC cancer   21 ( 1 )   266   2021年03月

Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer.

Kubota Y, Hatakeyama S, Yoneyama T, Yoneyama MS, Hamano I, Konishi S, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

World journal of urology   39 ( 9 )   3265 - 3271   2021年03月

Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study).

Kodama H, Hatakeyama S, Momota M, Togashi K, Hamaya T, Hamano I, Fujita N, Kojima Y, Okamoto T, Yoneyama T, Yamamoto H, Yoshikawa K, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   39 ( 3 )   191.e1-191.e8 - 191.e8   2021年03月

Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study).

Iwamura H, Hatakeyama S, Momota M, Kojima Y, Narita T, Okamoto T, Fujita N, Hamano I, Togashi K, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Translational andrology and urology   10 ( 3 )   1143 - 1151   2021年03月

Impact of symptomatic recurrence on oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Urologic oncology   39 ( 3 )   194.e9-194.e16 - 194.e16   2021年03月

Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.

Fujita N, Hatakeyama S, Okita K, Momota M, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Urologic oncology   39 ( 3 )   191.e9-191.e16 - 191.e16   2021年03月

Ghrelin after chemotherapy as a prognostic predictor of progression-free survival in patients with muscle-invasive bladder cancer.

Tomioka M, Yoneyama T, Tobisawa Y, Kawase K, Nakai C, Takai M, Kato D, Iinuma K, Nakane K, Mizutani K, Hashimoto Y, Koie T

Translational andrology and urology   10 ( 3 )   1192 - 1201   2021年03月

The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).

Togashi K, Hatakeyama S, Kojima Y, Momota M, Narita T, Iwamura H, Hamano I, Hamaya T, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   39 ( 3 )   192.e7-192.e14 - 192.e14   2021年03月

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study

Tomoko Hamaya, Shingo Hatakeyama, Toshikazu Tanaka, Yuka Kubota, Kyo Togashi, Shogo Hosogoe, Naoki Fujita, Ayumu Kusaka, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BJU International   128 ( 4 )   468 - 476   2021年02月

Long-term chronological changes in urination status of patients who underwent ileal neobladder reconstruction at a single institution.

Koie T, Hashimoto Y, Imai A, Yoneyama T, Tobisawa Y, Tanaka T, Noro D, Oikawa M, Suzuki T

International urology and nephrology   53 ( 2 )   275 - 280   2021年02月

N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.

Kodama H, Yoneyama T, Tanaka T, Noro D, Tobisawa Y, Yamamoto H, Suto S, Hatakeyama S, Mori K, Yoneyama T, Hashimoto Y, Kakizaki I, Nakaji S, Ohyama C

Cancer medicine   10 ( 4 )   1297 - 1313   2021年02月

Correction to: Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy.

Yoneyama T, Hatakeyama S, Sutoh Yoneyama M, Yoshiya T, Uemura T, Ishizu T, Suzuki M, Hachinohe S, Ishiyama S, Nonaka M, Fukuda MN, Ohyama C

BMC cancer   21 ( 1 )   105 - 105   2021年01月

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicenter retrospective study.

Tomoko Hamaya, Shingo Hatakeyama, Toshikazu Tanaka, Yuka Kubota, Kyo Togashi, Shogo Hosogoe, Naoki Fujita, Ayumu Kusaka, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BJU international   2021年01月

N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.

Hirotake Kodama, Tohru Yoneyama, Toshikazu Tanaka, Daisuke Noro, Yuki Tobisawa, Hayato Yamamoto, Shinichiro Suto, Shingo Hatakeyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Ikuko Kakizaki, Shigeyuki Nakaji, Chikara Ohyama

Cancer medicine   2021年01月

Tumor vasculature-targeted ¹⁰B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy.

Yoneyama T, Hatakeyama S, Sutoh Yoneyama M, Yoshiya T, Uemura T, Ishizu T, Suzuki M, Hachinohe S, Ishiyama S, Nonaka M, Fukuda MN, Ohyama C

BMC cancer   21 ( 1 )   72 - 72   2021年01月

Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer.

Fujita N, Hatakeyama S, Okita K, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Urologic oncology   39 ( 1 )   75.e9-75.e16 - 75.e16   2021年01月

Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).

Hamaya T, Hatakeyama S, Momota M, Narita T, Iwamura H, Kojima Y, Hamano I, Fujita N, Okamoto T, Togashi K, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

International journal of clinical oncology   26 ( 1 )   199 - 206   2021年01月

Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study.

Kido K, Hatakeyama S, Numakura K, Tanaka T, Oikawa M, Noro D, Hosogoe S, Narita S, Inoue T, Yoneyama T, Ito H, Nishimura S, Hashimoto Y, Kawaguchi T, Habuchi T, Ohyama C

International journal of clinical oncology   26 ( 1 )   154 - 162   2021年01月

Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in Japan.

Konishi S, Hatakeyama S, Imai A, Kumagai M, Okita K, Togashi K, Hamaya T, Hamano I, Okamoto T, Iwamura H, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Lower urinary tract symptoms   13 ( 1 )   56 - 63   2021年01月

A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.

Konishi S, Hatakeyama S, Imai A, Kumagai M, Okamoto T, Okita K, Hamano I, Narita T, Kojima Y, Iwamura H, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

Urologia internationalis   105 ( 3-4 )   232 - 239   2021年

尿路結石形成に関与する糖鎖変異オステオポンチンの検索

阿南 剛, 米山 徹, 野呂 大輔, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力

日本内分泌学会雑誌   97 ( S.Update )   47 - 49   2021年

Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years.

Togashi K, Hatakeyama S, Okamoto T, Kojima Y, Iwamura H, Fujita N, Narita T, Hamano I, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   39 ( 10 )   729.e17-729.e25 - 729.e25   2020年12月

Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.

Hirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Toshikazu Tanaka, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Tadashi Yoshizawa, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Chikara Ohyama

Urologic oncology   2020年12月

A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.

Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Teppei Okamoto, Kazutaka Okita, Itsuto Hamano, Takuma Narita, Yuta Kojima, Hiromichi Iwamura, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologia internationalis   1 - 8   2020年12月

Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study.

Tanaka T, Hatakeyama S, Numakura K, Kido K, Noro D, Oikawa M, Hosogoe S, Tokui N, Yamamoto H, Narita S, Ito H, Yoneyama T, Hashimoto Y, Kawaguchi T, Habuchi T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   27 ( 12 )   1095 - 1100   2020年12月

One-surgeon basketing technique for stone extraction during flexible ureteroscopy for urolithiasis: A comparison between novice and expert surgeons.

Anan G, Komatsu K, Hatakeyama S, Iwamura H, Kohada Y, Mikami J, Ito J, Kaiho Y, Shimbo M, Endo F, Yoneyama T, Hashimoto Y, Ohyama C, Hattori K, Sato M

International journal of urology : official journal of the Japanese Urological Association   27 ( 12 )   1072 - 1077   2020年12月

去勢抵抗性前立腺癌におけるCell-free DNAのAR amplificationは予後不良因子である

小玉 寛健, 畠山 真吾, 小西 栄, 久保田 優花, 相馬 理, 松本 哲平, 岡本 哲平, 米山 徹, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 大山 力

日本泌尿器科学会総会   108回   851 - 851   2020年12月

尿路結石の発生と予防に対する基礎研究の進歩 尿路結石と糖鎖 オステオポンチン糖鎖変異の検索

阿南 剛, 米山 徹, 野呂 大輔, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力

日本泌尿器科学会総会   108回   283 - 283   2020年12月

腫瘍血管内皮を標的にした新規ホウ素中性子捕捉療法による膀胱癌治療法の開発

畠山 真吾, 米山 徹, 米山 美穂子, 山本 勇人, 米山 高弘, 橋本 安弘, 石山 新太郎, 鈴木 実, 大山 力

日本泌尿器科学会総会   108回   885 - 885   2020年12月

Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).

Tomoko Hamaya, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Yuta Kojima, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Kyo Togashi, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of clinical oncology   2020年10月

Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   38 ( 10 )   795.e9 - 795.e17   2020年10月

Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Yasushi Mariya, Chikara Ohyama

Clinical genitourinary cancer   18 ( 5 )   e523 - e530   2020年10月

Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Urologic oncology   38 ( 10 )   795.e9-795.e17 - 795.e17   2020年10月

尿路結石形成に関与する糖鎖変異オステオポンチンの検索

阿南 剛, 米山 徹, 野呂 大輔, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 伊藤 淳, 海法 康裕, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力

日本内分泌学会雑誌   96 ( 2 )   528 - 528   2020年10月

Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Mariya Y, Ohyama C

Clinical genitourinary cancer   18 ( 5 )   e523-e530 - e530   2020年10月

Impact of symptomatic recurrence on oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   2020年09月

Long-term chronological changes in urination status of patients who underwent ileal neobladder reconstruction at a single institution.

Takuya Koie, Yasuhiro Hashimoto, Atsushi Imai, Tohru Yoneyama, Yuki Tobisawa, Toshikazu Tanaka, Daisuke Noro, Masaaki Oikawa, Tadashi Suzuki

International urology and nephrology   2020年09月

The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).

Kyo Togashi, Shingo Hatakeyama, Yuta Kojima, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Itsuto Hamano, Tomoko Hamaya, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   2020年08月

Geriatric 8 screening of frailty in patients with prostate cancer.

Masaki Momota, Shingo Hatakeyama, Osamu Soma, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   27 ( 8 )   642 - 648   2020年08月

Living Kidney Transplantation From Marginal Donors Presents Feasible Donor Renal Function Despite Inferior Recipient Renal Function.

Itsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, Reiichi Murakami, Tomoko Hamaya, Kyo Togashi, Yuichiro Suzuki, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama

Transplantation proceedings   52 ( 6 )   1723 - 1728   2020年08月

The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

International urology and nephrology   52 ( 8 )   1421 - 1428   2020年08月

Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.

Fujita N, Hatakeyama S, Momota M, Kido K, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Urologic oncology   38 ( 8 )   684.e17-684.e24 - 684.e24   2020年08月

Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.

Okita K, Hatakeyama S, Momota M, Soma O, Hamano I, Tanaka T, Iwamura H, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   27 ( 8 )   649 - 654   2020年08月

Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   2020年07月

Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study).

Hirotake Kodama, Shingo Hatakeyama, Masaki Momota, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Naoki Fujita, Yuta Kojima, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   2020年07月

Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   2020年07月

The impact of microalbuminuria on overactive bladders: Results from a community-based four-year longitudinal study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Masataka Ando, Jung Songee, Atsushi Imai, Itsuto Hamano, Naoki Fujita, Akiko Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Neurourology and urodynamics   39 ( 5 )   1567 - 1575   2020年07月

Survey on attitudes toward brain-dead and living donor transplantation in medical students: a cross-sectional study in Japan.

Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama

Clinical and experimental nephrology   24 ( 7 )   638 - 645   2020年07月

Utility of plasma cell-free DNA in metastatic castration-resistant prostate cancer.

Itsuto Hamano, Shingo Hatakeyama, Tomoko Hamaya, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

IJU case reports   3 ( 4 )   141 - 144   2020年07月

Living Kidney Transplantation From Marginal Donors Presents Feasible Donor Renal Function Despite Inferior Recipient Renal Function.

Hamano I, Hatakeyama S, Fujita T, Murakami R, Hamaya T, Togashi K, Suzuki Y, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Narumi S, Tomita H, Ohyama C

Transplantation proceedings   52 ( 6 )   1723 - 1728   2020年07月

Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.

Hamano I, Hatakeyama S, Fujita T, Murakami R, Hamaya T, Togashi K, Suzuki Y, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Narumi S, Tomita H, Ohyama C

Transplantation proceedings   52 ( 6 )   1700 - 1704   2020年07月

Frailty is a predictor of moderate to severe pain after robot-assisted laparoscopic prostatectomy: A case-control study (FRAP study).

Momota M, Hatakeyama S, Soma O, Hamano I, Fujita N, Okamoto T, Togashi K, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

BJUI compass   1 ( 3 )   100 - 107   2020年07月

Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer

Itsuto Hamano, Shingo Hatakeyama, Tomoko Hamaya, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

IJU Case Reports   3 ( 4 )   141 - 144   2020年06月

Geriatric 8 screening of frailty in patients with prostate cancer

Masaki Momota, Shingo Hatakeyama, Osamu Soma, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International Journal of Urology   27 ( 8 )   642 - 648   2020年06月

尿路結石バイオマーカーとして尿中糖鎖変異オステオポンチン(PolyLacNAc-OPN)の同定

阿南 剛, 米山 徹, 野呂 大輔, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 伊藤 淳, 海法 康裕, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力

泌尿器科紀要   66 ( 6 )   180 - 180   2020年06月

The impact of microalbuminuria on overactive bladders: Results from a community‐based four‐year longitudinal study in Japan

Teppei Okamoto, Shingo Hatakeyama, Masataka Ando, Jung Songee, Atsushi Imai, Itsuto Hamano, Naoki Fujita, Akiko Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Neurourology and Urodynamics   39 ( 5 )   1567 - 1575   2020年05月

Altered gut microbiome associated with overactive bladder and daily urinary urgency.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

World journal of urology   2020年05月

Altered gut microbiome associated with overactive bladder and daily urinary urgency.

Okamoto T, Hatakeyama S, Imai A, Yamamoto H, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C

World journal of urology   39 ( 3 )   847 - 853   2020年05月

Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Koichi Kido, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   38 ( 8 )   684.e17 - 684.e24   2020年04月

Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan-Japan UTUC Collaboration Cohort.

Hao Lun Luo, Chikara Ohyama, Shingo Hatakeyama, Hung Jen Wang, Tohru Yoneyama, Wen Chou Yang, Yao Chi Chuang, Yen Ta Chen, Wei Chin Lee, Yuan Tso Cheng, Chih Hsiung Kang, Po Hui Chiang

International journal of urology : official journal of the Japanese Urological Association   27 ( 4 )   327 - 332   2020年04月

STone Episode Prediction: Development and validation of the prediction nomogram for urolithiasis.

Kazutaka Okita, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Itsuto Hamano, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Tadashi Suzuki, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   27 ( 4 )   344 - 349   2020年04月

Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan‐Japan UTUC Collaboration Cohort

Hao Lun Luo, Chikara Ohyama, Shingo Hatakeyama, Hung Jen Wang, Tohru Yoneyama, Wen Chou Yang, Yao Chi Chuang, Yen Ta Chen, Wei Chin Lee, Yuan Tso Cheng, Chih Hsiung Kang, Po Hui Chiang

International Journal of Urology   27 ( 4 )   327 - 332   2020年04月

Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.

Itsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, Reiichi Murakami, Tomoko Hamaya, Kyo Togashi, Yuichiro Suzuki, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama

Transplantation proceedings   52 ( 6 )   1700 - 1704   2020年03月

Preoperative chronic kidney disease predicts poor prognosis in patients with primary non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   38 ( 8 )   684.e1 - 684.e8   2020年03月

The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

World journal of urology   2020年03月

Serum N-glycan profiling can predict biopsy-proven graft rejection after living kidney transplantation.

Soma O, Hatakeyama S, Yoneyama T, Saito M, Sasaki H, Tobisawa Y, Noro D, Suzuki Y, Tanaka M, Nishimura SI, Harada H, Ishida H, Tanabe K, Satoh S, Ohyama C

Clinical and experimental nephrology   24 ( 2 )   174 - 184   2020年02月

Impact of the Proportion of Biopsy Positive Core in Predicting Biochemical Recurrence in Patients with Pathological Pt2 and Negative Resection Margin Status after Radical Prostatectomy.

Masaaki Oikawa, Toshikazu Tanaka, Takuma Narita, Daisuke Noro, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Hirotake Kodama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Pathology oncology research : POR   2020年01月

Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy.

Hirotake Kodama, Takuya Koie, Masaaki Oikawa, Takuma Narita, Toshikazu Tanaka, Daisuke Noro, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International urology and nephrology   2020年01月

Impact of the Proportion of Biopsy Positive Core in Predicting Biochemical Recurrence in Patients with Pathological Pt2 and Negative Resection Margin Status after Radical Prostatectomy

米山 徹

Pathology & Oncology Research   -   2020年

マージナルドナーからの生体腎移植における移植成績ならびにドナー・レシピエント腎機能の検討

濱野 逸人, 畠山 真吾, 濱谷 智子, 百田 匡毅, 成田 拓磨, 小島 由太, 岩村 大径, 米山 徹, 岡本 哲平, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力

移植   55 ( Supplement )   356_1 - 356_1   2020年

当科におけるABO不適合移植の移植成績

濱谷 智子, 濱野 逸人, 畠山 真吾, 藤田 雄, 村上 礼一, 岡本 哲平, 鈴木 裕一朗, 山本 勇人, 米山 徹, 米山 高弘, 橋本 安弘, 齋藤 久夫, 鈴木 唯司, 大山 力

移植   55 ( Supplement )   360_1 - 360_1   2020年

前立腺がんの過剰診断・過剰治療を回避する糖鎖関連バイオマーカー

米山 徹, 飛澤 悠葵, 畠山 真吾, 大山 力

泌尿器科   11(1)   99 - 110   2020年

The Impact of Glycosylation of Osteopontin on Urinary Stone Formation.

Go Anan, Tohru Yoneyama, Daisuke Noro, Yuki Tobisawa, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiromichi Iwamura, Yuki Kohada, Jotaro Mikami, Jun Ito, Yasuhiro Kaiho, Takahiro Yoneyama, Yasuhiro Hashimoto, Makoto Sato, Chikara Ohyama

International journal of molecular sciences   21 ( 1 )   2019年12月

The Relationship Between Gait Function and Erectile Dysfunction: Results from a Community-Based Cross-Sectional Study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Sakae Konishi, Kazutaka Okita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

The journal of sexual medicine   16 ( 12 )   1922 - 1929   2019年12月

Serum N-glycan profiling can predict biopsy-proven graft rejection after living kidney transplantation.

Osamu Soma, Shingo Hatakeyama, Tohru Yoneyama, Mitsuru Saito, Hideo Sasaki, Yuki Tobisawa, Daisuke Noro, Yuichiro Suzuki, Masakazu Tanaka, Shin-Ichiro Nishimura, Hiroshi Harada, Hideki Ishida, Kazunari Tanabe, Shigeru Satoh, Chikara Ohyama

Clinical and experimental nephrology   2019年11月

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer.

Teppei Matsumoto, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hiroyuki Ito, Shin-Ichiro Nishimura, Chikara Ohyama

Scientific reports   9 ( 1 )   16761 - 16761   2019年11月

Bilateral scrotal mass mimicking testicular cancer: An unusual presentation of sarcoidosis.

Sakae Konishi, Shingo Hatakeyama, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   26 ( 11 )   1079 - 1081   2019年11月

Sleep Disturbance Has a Higher Impact on General and Mental Quality of Life Reduction than Nocturia: Results from the Community Health Survey in Japan.

Kido K, Hatakeyama S, Imai A, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C

European urology focus   5 ( 6 )   1120 - 1126   2019年11月

The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma.

Momota M, Hatakeyama S, Tokui N, Sato T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Narita S, Kawaguchi T, Ohyama C

European urology focus   5 ( 6 )   1066 - 1073   2019年11月

Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma.

Sappaya Suppanuntaroek, Shingo Hatakeyama, Naoki Fujita, Yuka Kubota, Yuichiro Suzuki, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Kazuyuki Mori, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of clinical oncology   2019年10月

Relationship between frailty and lower urinary tract symptoms among community-dwelling adults.

Osamu Soma, Shingo Hatakeyama, Atsushi Imai, Teppei Matsumoto, Itsuto Hamano, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

Lower urinary tract symptoms   2019年10月

C-reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma.

Sakae Konishi, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   26 ( 10 )   992 - 998   2019年10月

Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study.

Konishi S, Hatakeyama S, Numakura K, Narita S, Inoue T, Saito M, Tokui N, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Narita S, Kawaguchi T, Habuchi T, Ohyama C

Clinical genitourinary cancer   17 ( 5 )   e1080 - e1089   2019年10月

Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.

Osamu Soma, Shingo Hatakeyama, Teppei Okamoto, Naoki Fujita, Itsuto Hamano, Toshikazu Tanaka, Masaki Momota, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Hisao Saitoh, Shigeyuki Nakaji, Tadashi Suzuki, Chikara Ohyama

Medical oncology (Northwood, London, England)   36 ( 10 )   88 - 88   2019年09月

Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection.

Tohru Yoneyama, Yuki Tobisawa, Tomonori Kaneko, Takatoshi Kaya, Shingo Hatakeyama, Kazuyuki Mori, Mihoko Sutoh Yoneyama, Teppei Okubo, Koji Mitsuzuka, Wilhelmina Duivenvoorden, Jehonathan H Pinthus, Yasuhiro Hashimoto, Akihiro Ito, Takuya Koie, Yoshihiko Suda, Robert A Gardiner, Chikara Ohyama

Cancer science   110 ( 8 )   2573 - 2589   2019年08月

Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection.

Yoneyama T, Tobisawa Y, Kaneko T, Kaya T, Hatakeyama S, Mori K, Sutoh Yoneyama M, Okubo T, Mitsuzuka K, Duivenvoorden W, Pinthus JH, Hashimoto Y, Ito A, Koie T, Suda Y, Gardiner RA, Ohyama C

Cancer science   110 ( 8 )   2573 - 2589   2019年08月

C‐reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma

Sakae Konishi, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama

International Journal of Urology   26 ( 10 )   992 - 998   2019年07月

Robot-assisted radical cystectomy in a patient with muscle-invasive bladder cancer following radiotherapy for prostate cancer.

Kubota Y, Hatakeyama S, Hashimoto T, Fujita N, Okamoto T, Suzuki Y, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

IJU case reports   2 ( 4 )   236 - 239   2019年07月

Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.

Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shunji Narumi, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama

Clinical and experimental nephrology   23 ( 6 )   807 - 813   2019年06月

Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.

Hamano I, Hatakeyama S, Yamamoto H, Fujita T, Murakami R, Shimada M, Imai A, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Narumi S, Saitoh H, Suzuki T, Tomita H, Ohyama C

Clinical and experimental nephrology   23 ( 6 )   807 - 813   2019年06月

Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma.

Okita K, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Fujita N, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C

Clinical genitourinary cancer   17 ( 3 )   e440 - e446   2019年06月

Renal cell carcinoma in a lumbar ectopic kidney.

Hamano I, Hatakeyama S, Soma O, Ishibashi Y, Yoneyama T, Yoneyama T, Hashimoto Y, Nishimura S, Koie T, Ohyama C

IJU case reports   2 ( 3 )   124 - 127   2019年05月

Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.

Matsumoto T, Hatakeyama S, Imai A, Tanaka T, Hagiwara K, Konishi S, Okita K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C

BJU international   123 ( 5 )   877 - 884   2019年05月

尿路結石形成に関与する尿中糖鎖変異オステオポンチン(PolyLac-OPN)のバイオマーカーの可能性

阿南 剛, 米山 徹, 畠山 真吾, 飛澤 悠葵, 米山 美穂子, 岩村 大径, 伊藤 淳, 海法 康裕, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 鈴木 唯司, 佐藤 信, 大山 力

日本内分泌学会雑誌   95 ( 1 )   379 - 379   2019年04月

Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open-label, multicenter study.

Matsumoto T, Hatakeyama S, Narita T, Yoneyama T, Hashimoto Y, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   26 ( 4 )   522 - 523   2019年04月

尿路結石形成に関与する尿中オステオポンチンの糖鎖変異

阿南 剛, 米山 徹, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 古家 琢也, 鈴木 唯司, 佐藤 信, 大山 力

日本尿路結石症学会誌   17 ( 2 )   117 - 119   2019年03月

前立腺がんの過剰診断を克服する診断マーカーの開発

米山 徹, 大山 力

腎臓内科・泌尿器科   9(4)   349 - 357   2019年

Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.

Hosogoe S, Hatakeyama S, Kusaka A, Hamano I, Iwamura H, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

European urology focus   4 ( 6 )   946 - 953   2018年12月

Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.

Naoki Fujita, Takuya Koie, Yasuhiro Hashimoto, Takuma Narita, Yuki Tobisawa, Toshikazu Tanaka, Daisuke Noro, Masaaki Oikawa, Kazuhisa Hagiwara, Tohru Yoneyama, Atsushi Imai, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Chikara Ohyama

International urology and nephrology   50 ( 11 )   1999 - 2005   2018年11月

Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.

Fujita N, Koie T, Hashimoto Y, Narita T, Tobisawa Y, Tanaka T, Noro D, Oikawa M, Hagiwara K, Yoneyama T, Imai A, Yamamoto H, Hatakeyama S, Yoneyama T, Ohyama C

International urology and nephrology   50 ( 11 )   1999 - 2005   2018年11月

Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.

Teppei Matsumoto, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Kazuhisa Hagiwara, Sakae Konishi, Kazutaka Okita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

BJU international   2018年09月

Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.

Itsuto Hamano, Shingo Hatakeyama, Rika Nakamura, Rie Fukuhara, Daisuke Noro, Toshikazu Tanaka, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yoshihito Yokoyama, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   25 ( 9 )   817 - 824   2018年09月

Synthetic glycopeptides as a designated standard in focused glycoproteomics to discover serum cancer biomarkers.

K V Yogesh, Toshiya Kamiyama, Chikara Ohyama, Tohru Yoneyama, Kazuhiro Nouso, Satoshi Kimura, Hiroshi Hinou, Shin-Ichiro Nishimura

MedChemComm   9 ( 8 )   1351 - 1358   2018年08月

Synthetic glycopeptides as a designated standard in focused glycoproteomics to discover serum cancer biomarkers.

Yogesh KV, Kamiyama T, Ohyama C, Yoneyama T, Nouso K, Kimura S, Hinou H, Nishimura SI

MedChemComm   9 ( 8 )   1351 - 1358   2018年08月

Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values

Itsuto Hamano, Shingo Hatakeyama, Rika Nakamura, Rie Fukuhara, Daisuke Noro, Toshikazu Tanaka, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yoshihito Yokoyama, Chikara Ohyama

International Journal of Urology   25 ( 9 )   817 - 824   2018年07月

Sleep Disturbance Has a Higher Impact on General and Mental Quality of Life Reduction than Nocturia: Results from the Community Health Survey in Japan.

Koichi Kido, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

European urology focus   2018年05月

Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Masaki Momota, Shingo Hatakeyama, Hayato Yamamoto, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   9 ( 33 )   23047 - 23057   2018年05月

Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Momota M, Hatakeyama S, Yamamoto H, Iwamura H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Iwabuchi I, Ogasawara M, Kawaguchi T, Ohyama C

Oncotarget   9 ( 33 )   23047 - 23057   2018年05月

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.

Osamu Soma, Shingo Hatakeyama, Teppei Okamoto, Naoki Fujita, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

Oncotarget   9 ( 25 )   17396 - 17405   2018年04月

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.

Soma O, Hatakeyama S, Okamoto T, Fujita N, Matsumoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C

Oncotarget   9 ( 25 )   17396 - 17405   2018年04月

Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy.

Horiguchi H, Yoneyama T, Hatakeyama S, Tokui N, Sato T, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Hashimoto Y, Koie T, Yoshikawa K, Narita S, Kawaguchi T, Ohyama C

Medical oncology (Northwood, London, England)   35 ( 4 )   41   2018年04月

The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma.

Masaki Momota, Shingo Hatakeyama, Noriko Tokui, Tendo Sato, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Satoshi Narita, Toshiaki Kawaguchi, Chikara Ohyama

European urology focus   2018年03月

Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Koichi Kido, Shingo Hatakeyama, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama

International journal of clinical oncology   2018年02月

Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Kido K, Hatakeyama S, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Iwabuchi I, Ogasawara M, Kawaguchi T, Ohyama C

International journal of clinical oncology   23 ( 4 )   1 - 8   2018年02月

Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma.

Hirotaka Horiguchi, Shingo Hatakeyama, Go Anan, Yuka Kubota, Hirotake Kodama, Masaki Momota, Koichi Kido, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget   9 ( 9 )   8746 - 8755   2018年02月

Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava.

Tanaka Y, Hatakeyama S, Hosogoe S, Tanaka T, Hamano I, Kusaka A, Iwamura H, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

International journal of clinical oncology   23 ( 1 )   134 - 141   2018年02月

Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma

Hirotaka Horiguchi, Shingo Hatakeyama, Go Anan, Yuka Kubota, Hirotake Kodama, Masaki Momota, Koichi Kido, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget   9 ( 9 )   8746 - 8755   2018年01月

Anti-tumor growth effect of STIM1 suppression

Han Chong, Yoneyama Tohru, Toyama Yuichi, Yonekura Manabu, Ohyama Chikara, Murakami Manabu

Proceedings for Annual Meeting of The Japanese Pharmacological Society   WCP2018 ( 0 )   PO4-6-18   2018年

表面プラズモン共鳴励起増強蛍光分光（SPFS）を用いた高感 LacdiNAc-PSA測定法の開発

金子 智典, 彼谷 高敏, 米山 徹, 飛澤 悠葵, 畠山 真吾, 橋本 安弘, 古家 琢也, 大山 力, 須田 美彦

日本分子腫瘍マーカー研究会誌   33 ( 0 )   19 - 20   2018年

Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.

Toshikazu Tanaka, Tohru Yoneyama, Daisuke Noro, Kengo Imanishi, Yuta Kojima, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Shizuka Kurauchi, Ippei Takahashi, Chikara Ohyama

International journal of molecular sciences   18 ( 12 )   2017年12月

Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.

Tanaka T, Yoneyama T, Noro D, Imanishi K, Kojima Y, Hatakeyama S, Tobisawa Y, Mori K, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Tanaka M, Nishimura SI, Kurauchi S, Takahashi I, Ohyama C

International journal of molecular sciences   18 ( 12 )   2017年12月

Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.

Naoki Fujita, Takuya Koie, Chikara Ohyama, Yoshimi Tanaka, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Yasuhiro Hashimoto

International journal of clinical oncology   22 ( 6 )   1087 - 1093   2017年12月

Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.

Fujita N, Koie T, Ohyama C, Tanaka Y, Soma O, Matsumoto T, Yamamoto H, Imai A, Tobisawa Y, Yoneyama T, Hatakeyama S, Hashimoto Y

International journal of clinical oncology   22 ( 6 )   1087 - 1093   2017年12月

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.

Yuka Kubota, Shingo Hatakeyama, Toshikazu Tanaka, Naoki Fujita, Hiromichi Iwamura, Jotaro Mikami, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   8 ( 60 )   101500 - 101508   2017年11月

Significance of preoperative butyrylcholinesterase level as an independent predictor of survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy

Daisuke Noro, Takuya Koie, Yasuhiro Hashimoto, Toshikazu Tanaka, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Shingo Hatakeyama, Hayato Yamamoto, Masato Kitayama, Kazuyoshi Hirota

Japanese Journal of Clinical Oncology   48 ( 2 )   184 - 189   2017年11月

Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.

Toshikazu Tanaka, Takuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, Atsushi Imai, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Tohru Yoneyama, Hirotaka Horiguchi, Hirotake Kodama, Takahiro Yoneyama

Japanese journal of clinical oncology   47 ( 11 )   1078 - 1082   2017年11月

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.

Go Anan, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Toshikazu Tanaka, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget   8 ( 49 )   86130 - 86142   2017年10月

Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Hirotake Kodama, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Go Anan, Ken Fukushi, Takuma Narita, Toshikazu Tanaka, Yuka Kubota, Hirotaka Horiguchi, Masaki Momota, Koichi Kido, Teppei Matsumoto, Osamu Soma, Itsuto Hamano, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget   8 ( 47 )   83183 - 83194   2017年10月

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.

Anan G, Hatakeyama S, Fujita N, Iwamura H, Tanaka T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Sato M, Ohyama C

Oncotarget   8 ( 49 )   86130 - 86142   2017年10月

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.

Itsuto Hamano, Shingo Hatakeyama, Hiromichi Iwamurau, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Ayumu Kusaka, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   8 ( 37 )   61404 - 61414   2017年09月

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.

Ayumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   8 ( 39 )   65492 - 65505   2017年09月

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction.

Takuma Narita, Shingo Hatakeyama, Takuya Koie, Shogo Hosogoe, Teppei Matsumoto, Osamu Soma, Hayato Yamamoto, Tohru Yoneyama, Yuki Tobisawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BMC urology   17 ( 1 )   72 - 72   2017年08月

Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma

Hirotake Kodama, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Go Anan, Ken Fukushi, Takuma Narita, Toshikazu Tanaka, Yuka Kubota, Hirotaka Horiguchi, Masaki Momota, Koichi Kido, Teppei Matsumoto, Osamu Soma, Itsuto Hamano, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget   8 ( 47 )   83183 - 83194   2017年08月

Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy

Toshikazu Tanaka, Takuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, Atsushi Imai, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Tohru Yoneyama, Hirotaka Horiguchi, Hirotake Kodama, Takahiro Yoneyama

Japanese Journal of Clinical Oncology   47 ( 11 )   1078 - 1082   2017年08月

Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant.

Daisuke Noro, Tohru Yoneyama, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Hideo Sasaki, Mitsuru Saito, Hiroshi Harada, Tatsuya Chikaraishi, Hideki Ishida, Kazunari Tanabe, Shigeru Satoh, Chikara Ohyama

International journal of molecular sciences   18 ( 8 )   2017年08月

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction.

Narita T, Hatakeyama S, Koie T, Hosogoe S, Matsumoto T, Soma O, Yamamoto H, Yoneyama T, Tobisawa Y, Yoneyama T, Hashimoto Y, Ohyama C

BMC urology   17 ( 1 )   72   2017年08月

Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant.

Noro D, Yoneyama T, Hatakeyama S, Tobisawa Y, Mori K, Hashimoto Y, Koie T, Tanaka M, Nishimura SI, Sasaki H, Saito M, Harada H, Chikaraishi T, Ishida H, Tanabe K, Satoh S, Ohyama C

International journal of molecular sciences   18 ( 8 )   2017年08月

Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava.

Yoshimi Tanaka, Shingo Hatakeyama, Shogo Hosogoe, Toshikazu Tanaka, Itsuto Hamano, Ayumu Kusaka, Hiromich Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology   2017年07月

Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma.

Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka, Itsuto Hamano, Yoshimi Tanaka, Kazuhisa Hagiwara, Hideaki Hirai, Satoko Morohashi, Hiroshi Kijima, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Oncotarget   8 ( 30 )   49749 - 49756   2017年07月

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer

Ayumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   8 ( 39 )   65492 - 65505   2017年07月

Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma.

Hosogoe S, Hatakeyama S, Kusaka A, Hamano I, Tanaka Y, Hagiwara K, Hirai H, Morohashi S, Kijima H, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

Oncotarget   8 ( 30 )   49749 - 49756   2017年07月

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.

Tanaka Y, Hatakeyama S, Tanaka T, Yamamoto H, Narita T, Hamano I, Matsumoto T, Soma O, Okamoto T, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Takahashi I, Nakaji S, Terayama Y, Funyu T, Ohyama C

PloS one   12 ( 7 )   e0182136   2017年07月

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer

Itsuto Hamano, Shingo Hatakeyama, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Ayumu Kusaka, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   8 ( 37 )   61404 - 61414   2017年05月

Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.

Ayumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Medical oncology (Northwood, London, England)   34 ( 5 )   90 - 90   2017年05月

Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma.

Fukushi K, Narita T, Hatakeyama S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   24 ( 5 )   361 - 366   2017年05月

Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: a single-center study.

Hagiwara K, Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Tobisawa Y, Yoneyama T

International urology and nephrology   49 ( 5 )   811 - 816   2017年05月

Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.

Kusaka A, Hatakeyama S, Hosogoe S, Hamano I, Iwamura H, Fujita N, Fukushi K, Narita T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C

Medical oncology (Northwood, London, England)   34 ( 5 )   90   2017年05月

Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.

Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

European urology focus   2017年04月

Clinical relevance of aortic calcification in urolithiasis patients.

Toshikazu Tanaka, Shingo Hatakeyama, Hayato Yamamoto, Takuma Narita, Itsuto Hamano, Teppei Matsumoto, Osamu Soma, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ippei Takahashi, Shigeyuki Nakaji, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

BMC urology   17 ( 1 )   25 - 25   2017年04月

Recent progress and perspectives on prostate cancer biomarkers.

Hatakeyama S, Yoneyama T, Tobisawa Y, Ohyama C

International journal of clinical oncology   22 ( 2 )   214 - 221   2017年04月

Clinical relevance of aortic calcification in urolithiasis patients.

Tanaka T, Hatakeyama S, Yamamoto H, Narita T, Hamano I, Matsumoto T, Soma O, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Takahashi I, Nakaji S, Terayama Y, Funyu T, Ohyama C

BMC urology   17 ( 1 )   25   2017年04月

Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.

Fukushi K, Narita T, Hatakeyama S, Yamamoto H, Soma O, Matsumoto T, Tobisawa Y, Yoneyama T, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

International journal of clinical oncology   22 ( 2 )   366 - 372   2017年04月

Clinical implications of serumN-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors

Takuma Narita, Shingo Hatakeyama, Tohru Yoneyama, Shintaro Narita, Shinichi Yamashita, Koji Mitsuzuka, Toshihiko Sakurai, Sadafumi Kawamura, Tatsuo Tochigi, Ippei Takahashi, Shigeyuki Nakaji, Yuki Tobisawa, Hayato Yamamoto, Takuya Koie, Norihiko Tsuchiya, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama

Cancer Medicine   6 ( 4 )   739 - 748   2017年03月

Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma.

Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   2017年03月

The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.

Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Yamauchi A, Shimazui T, Ohtani M

Japanese journal of clinical oncology   47 ( 3 )   252 - 256   2017年03月

An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.

Tomokazu Ishikawa, Tohru Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Tatsuo Kurosawa, Kenji Nakamura, Shintaro Narita, Koji Mitsuzuka, Wilhelmina Duivenvoorden, Jehonathan H Pinthus, Yasuhiro Hashimoto, Takuya Koie, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama

International journal of molecular sciences   18 ( 2 )   2017年02月

Effect of heparin bridged transrectal prostate biopsy on the risk of hemorrhage in patients requiring temporary discontinuation of warfarin.

Hamano Itsuto, Hatakeyama Shingo, Yoneyama Tohru, Tobisawa Yuki, Soma Osamu, Matsumoto Teppei

JOURNAL OF CLINICAL ONCOLOGY   35 ( 6 )   2017年02月

Impact of castration resistant status on overall survival for prostate cancer patients treated with radical prostatectomy.

Fujita Naoki, Koie Takuya, Yamamoto Hayato, Imai Atsushi, Tobisawa Yuki, Yoneyama Tohru

JOURNAL OF CLINICAL ONCOLOGY   35 ( 6 )   2017年02月

Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: A single-center study.

Hagiwara Kazuhisa, Koie Takuya, Tobisawa Yuki, Yamamoto Hayato, Imai Atsushi, Yoneyama Tohru

JOURNAL OF CLINICAL ONCOLOGY   35 ( 6 )   2017年02月

Aortic calcification burden predicts deterioration of renal function after radical nephrectomy.

Ken Fukushi, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Osamu Soma, Teppei Matsumoto, Itsuto Hamano, Takuma Narita, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

BMC urology   17 ( 1 )   13 - 13   2017年02月

[Development and Clinical Application of Glycan-Targeted Biomarkers for Prostate Cancer].

Ohyama C, Yoneyama T, Tobisawa Y, Ishikawa T, Hatakeyama S, Koie T, Mori K

Rinsho byori. The Japanese journal of clinical pathology   65 ( 2 )   210 - 217   2017年02月

Aortic calcification burden predicts deterioration of renal function after radical nephrectomy.

Fukushi K, Hatakeyama S, Yamamoto H, Tobisawa Y, Yoneyama T, Soma O, Matsumoto T, Hamano I, Narita T, Imai A, Yoneyama T, Hashimoto Y, Koie T, Terayama Y, Funyu T, Ohyama C

BMC urology   17 ( 1 )   13   2017年02月

[Development and Clinical Application of Glycan-Targeted Biomarkers for Prostate Cancer].

Ohyama C, Yoneyama T, Tobisawa Y, Ishikawa T, Hatakeyama S, Koie T, Mori K

Rinsho byori. The Japanese journal of clinical pathology   65 ( 2 )   210 - 217   2017年02月

Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.

Hagiwara K, Tobisawa Y, Kaya T, Kaneko T, Hatakeyama S, Mori K, Hashimoto Y, Koie T, Suda Y, Ohyama C, Yoneyama T

International journal of molecular sciences   18 ( 2 )   2017年02月

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.

Yoshimi Tanaka, Shingo Hatakeyama, Toshikazu Tanaka, Hayato Yamamoto, Takuma Narita, Itsuto Hamano, Teppei Matsumoto, Osamu Soma, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ippei Takahashi, Shigeyuki Nakaji, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

PloS one   12 ( 7 )   e0182136 - e0182136   2017年

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.

Kubota Y, Hatakeyama S, Tanaka T, Fujita N, Iwamura H, Mikami J, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Sasaki A, Kawaguchi T, Ohyama C

Oncotarget   8 ( 60 )   101500 - 101508   2017年

The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Atsushi Yamauchi, Toru Shimazui, Mikinobu Ohtani

Japanese journal of clinical oncology   2016年12月

Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.

Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Osamu Soma, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology   2016年12月

Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents.

Hamano I, Hatakeyama S, Yoneyama T, Tobisawa Y, Soma O, Matsumoto T, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

SpringerPlus   5 ( 1 )   1917   2016年12月

Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma

Masaaki Oikawa, Shingo Hatakeyama, Tohru Yoneyma, Yuki Tobisawa, Takuma Narita, Hayato Yamamoto, Yasuhiro Hashimoto, Takuya Koie, Shintaro Narita, Atsushi Sasaki, Norihiko Tsuchiya, Tomonori Habuchi, Ippei Takahashi, Shigeyuki Nakaji and Chikara Ohyama

European Urology Focus   2016年11月

Recent progress and perspectives on prostate cancer biomarkers.

Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Chikara Ohyama

International journal of clinical oncology   2016年10月

[Development of promising biomarkers for prostate cancer].

Tohru Yoneyama, Chikara Ohyama

Nihon rinsho. Japanese journal of clinical medicine   74 Suppl 3   191 - 195   2016年05月

Implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism.

Fujita N, Hatakeyama S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nigawara T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   23 ( 5 )   412 - 417   2016年05月

Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery.

Sato T, Hatakeyama S, Okamoto T, Yamamoto H, Hosogoe S, Tobisawa Y, Yoneyama T, Hashiba E, Yoneyama T, Hashimoto Y, Koie T, Hirota K, Ohyama C

PloS one   11 ( 5 )   e0153961   2016年05月

Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.

Koie T, Ohyama C, Hatakeyama S, Imai A, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Hosogoe S, Yamamoto H, Kitayama M, Hirota K

International journal of clinical oncology   21 ( 2 )   379 - 383   2016年04月

I‐branching N ‐acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling

Jotaro Mikami, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda

Cancer Science   107 ( 3 )   359 - 368   2016年02月

Implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism.

Naoki Fujita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Takeshi Nigawara, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   2016年02月

Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected].

Hatakeyama S, Koie T, Narita T, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

PloS one   11 ( 2 )   e0149544   2016年02月

Core 2 β-1, 6-N-acetylglucosaminyltransferase-1 expression in prostate biopsy specimen is an indicator of prostate cancer aggressiveness.

Tendo Sato, Tohru Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Yuta Kojima, Jotaro Mikami, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Biochemical and biophysical research communications   470 ( 1 )   150 - 156   2016年01月

Core 2 β-1, 6-N-acetylglucosaminyltransferase-1 expression in prostate biopsy specimen is an indicator of prostate cancer aggressiveness.

Sato T, Yoneyama T, Tobisawa Y, Hatakeyama S, Yamamoto H, Kojima Y, Mikami J, Mori K, Hashimoto Y, Koie T, Ohyama C, Biochemical, biophysical research communications

Biochemical and biophysical research communications   470 ( 1 )   150 - 156   2016年01月

Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents.

Itsuto Hamano, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

SpringerPlus   5 ( 1 )   1917 - 1917   2016年

特集 知っておきたい腎移植の最新情報-基礎から臨床まで I.基礎 ABO不適合移植における血液型抗原結合ペプチドの抗血栓・免疫応答抑制効果の可能性

畠山 真吾, 米山 徹, 飛澤 悠葵, 大山 力

臨床泌尿器科   69 ( 13 )   1093 - 1100   2015年12月

I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling.

Jotaro Mikami, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda

Cancer science   2015年12月

Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis.

Koie T, Mitsuzuka K, Yoneyama T, Narita S, Kawamura S, Kaiho Y, Tsuchiya N, Tochigi T, Habuchi T, Arai Y, Ohyama C, Yoneyama T, Tobisawa Y

International journal of clinical oncology   20 ( 5 )   1018 - 1025   2015年10月

Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.

Yuta Kojima, Tohru Yoneyama, Shingo Hatakeyama, Jotaro Mikami, Tendo Sato, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Minoru Fukuda, Yuki Tobisawa

PloS one   10 ( 9 )   e0138520 - e0138520   2015年09月

Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.

Takuya Koie, Chikara Ohyama, Shogo Hosogoe, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori

International urology and nephrology   47 ( 9 )   1509 - 1514   2015年09月

Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.

Kojima Y, Yoneyama T, Hatakeyama S, Mikami J, Sato T, Mori K, Hashimoto Y, Koie T, Ohyama C, Fukuda M, Tobisawa Y, PloS one

PloS one   10 ( 9 )   e0138520   2015年09月

Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.

Koie T, Ohyama C, Hosogoe S, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Mori K

International urology and nephrology   47 ( 9 )   1509 - 1514   2015年09月

Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.

Takuya Koie, Chikara Ohyama, Shingo Hatakeyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Shogo Hosogoe, Hayato Yamamoto, Masato Kitayama, Kazuyoshi Hirota

International journal of clinical oncology   2015年07月

Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer.

Yoneyama T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Hatakeyama S, Hashimoto Y, Koie T, Ohyama C

International journal of clinical oncology   20 ( 2 )   369 - 374   2015年04月

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan.

Koie T, Ohyama C, Yoneyama T, Yamamoto H, Imai A, Hatakeyama S, Hashimoto Y, Yoneyama T, Tobisawa Y, Mori K

BMC urology   15   32   2015年04月

Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis.

Takuya Koie, Koji Mitsuzuka, Takahiro Yoneyama, Shintaro Narita, Sadafumi Kawamura, Yasuhiro Kaiho, Norihiko Tsuchiya, Tatsuo Tochigi, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama, Tohru Yoneyama, Yuki Tobisawa

International journal of clinical oncology   2015年02月

Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy.

Koie T, Mitsuzuka K, Yoneyama T, Narita S, Kawamura S, Kaiho Y, Tsuchiya N, Tochigi T, Habuchi T, Arai Y, Ohyama C, Yoneyama T, Tobisawa Y

International journal of clinical oncology   20 ( 1 )   176 - 181   2015年02月

Quantification of Prostate Cancer-Associated Aberrant Glycosylation of Prostate-Specific Antigen

Chikara Ohyama, Takuya Koie, Tohru Yoneyama, Yuki Tobisawa

Glycoscience: Biology and Medicine   1373 - 1377   2015年01月

Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa

Medical oncology (Northwood, London, England)   32 ( 1 )   421 - 421   2015年01月

Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer.

Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y

Medical oncology (Northwood, London, England)   32 ( 1 )   421   2015年01月

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan.

Takuya Koie, Chikara Ohyama, Takahiro Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Kazuyuki Mori

BMC urology   15 ( 1 )   32 - 32   2015年

Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer.

Ishibashi Y, Tobisawa Y, Hatakeyama S, Ohashi T, Tanaka M, Narita S, Koie T, Habuchi T, Nishimura S, Ohyama C, Yoneyama T

The Prostate   74 ( 15 )   1521 - 1529   2014年11月

Testicular metastasis of prostate cancer: a case report.

Ayumu Kusaka, Takuya Koie, Hayato Yamamoto, Itsuto Hamano, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama

Case reports in oncology   7 ( 3 )   643 - 647   2014年09月

Testicular metastasis of prostate cancer: a case report.

Kusaka A, Koie T, Yamamoto H, Hamano I, Yoneyama T, Hashimoto Y, Ohyama C, Tobisawa Y, Yoneyama T

Case reports in oncology   7 ( 3 )   643 - 7   2014年09月

Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer.

Yusuke Ishibashi, Yuki Tobisawa, Shingo Hatakeyama, Tetsu Ohashi, Masakazu Tanaka, Shintaro Narita, Takuya Koie, Tomonori Habuchi, Shin-Ichiro Nishimura, Chikara Ohyama, Tohru Yoneyama

The Prostate   74 ( 15 )   1521 - 1529   2014年08月

Tubulocystic renal cell carcinoma in the left kidney: a case report.

Yusuke Ishibashi, Takuya Koie, Naoki Fujita, Tendo Satoh, Jotaro Mikami, Shingo Hatakeyama, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama

Journal of medical case reports   8   265 - 265   2014年07月

Tubulocystic renal cell carcinoma in the left kidney: a case report.

Ishibashi Y, Koie T, Fujita N, Satoh T, Mikami J, Hatakeyama S, Ohyama C, Tobisawa Y, Yoneyama T

Journal of medical case reports   8 ( 1 )   265   2014年07月

Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer.

Tohru Yoneyama, Chikara Ohyama, Shingo Hatakeyama, Shintaro Narita, Tomonori Habuchi, Takuya Koie, Kazuyuki Mori, Kazuya I P J Hidari, Maho Yamaguchi, Takashi Suzuki, Yuki Tobisawa

Biochemical and biophysical research communications   448 ( 4 )   390 - 396   2014年06月

Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer.

Yoneyama T, Ohyama C, Hatakeyama S, Narita S, Habuchi T, Koie T, Mori K, Hidari KI, Yamaguchi M, Suzuki T, Tobisawa Y

Biochemical and biophysical research communications   448 ( 4 )   390 - 396   2014年06月

Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer.

Takahiro Yoneyama, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology   2014年05月

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa

Medical oncology (Northwood, London, England)   31 ( 5 )   949 - 949   2014年05月

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer.

Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y

Medical oncology (Northwood, London, England)   31 ( 5 )   949   2014年05月

Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy.

Takuya Koie, Koji Mitsuzuka, Takahiro Yoneyama, Shintaro Narita, Sadafumi Kawamura, Yasuhiro Kaiho, Norihiko Tsuchiya, Tatsuo Tochigi, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama, Tohru Yoneyama, Yuki Tobisawa

International journal of clinical oncology   2014年04月

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Masahiko Aoki, Yoshihiro Takai

World journal of surgical oncology   12   134 - 134   2014年04月

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis.

Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Aoki M, Takai Y

World journal of surgical oncology   12   134   2014年04月

Serum N-glycan alteration associated with renal cell carcinoma detected by high throughput glycan analysis.

Shingo Hatakeyama, Maho Amano, Yuki Tobisawa, Tohru Yoneyama, Norihiko Tsuchiya, Tomonori Habuchi, Shin-Ichiro Nishimura, Chikara Ohyama

The Journal of urology   191 ( 3 )   805 - 813   2014年03月

Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience.

S Hatakeyama, T Fujita, R Murakami, Y Suzuki, N Sugiyama, H Yamamoto, A Okamoto, A Imai, Y Tobisawa, T Yoneyama, K Mori, T Yoneyama, Y Hashimoto, T Koie, S Narumi, C Ohyama

Transplantation proceedings   46 ( 2 )   445 - 448   2014年03月

Renal cell carcinoma detected by preoperative kidney transplant donor examination: a case report.

T Sato, Takahiro Yoneyama, K Hagiwara, T Narita, D Noro, T Tanaka, Y Tanaka, Y Tobisawa, Tohru Yoneyama, H Yamamoto, A Okamoto, A Imai, S Hatakeyama, Y Hashimoto, T Koie, C Ohyama

Transplantation proceedings   46 ( 2 )   634 - 636   2014年03月

BK virus-associated urothelial carcinoma of a ureter graft in a renal transplant recipient: a case report.

M Oikawa, S Hatakeyama, T Fujita, R Murakami, K Hagiwara, T Narita, D Noro, T Tanaka, Y Tanaka, Y Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Y Hashimoto, T Koie, S Narumi, C Ohyama

Transplantation proceedings   46 ( 2 )   616 - 619   2014年03月

BK virus-associated urothelial carcinoma of a ureter graft in a renal transplant recipient: a case report.

Oikawa M, Hatakeyama S, Fujita T, Murakami R, Hagiwara K, Narita T, Noro D, Tanaka T, Tanaka Y, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Narumi S, Ohyama C

Transplantation proceedings   46 ( 2 )   616 - 619   2014年03月

Renal cell carcinoma detected by preoperative kidney transplant donor examination: a case report.

Sato T, Yoneyama T, Hagiwara K, Narita T, Noro D, Tanaka T, Tanaka Y, Tobisawa Y, Yoneyama T, Yamamoto H, Okamoto A, Imai A, Hatakeyama S, Hashimoto Y, Koie T, Ohyama C

Transplantation proceedings   46 ( 2 )   634 - 636   2014年03月

SerumN-Glycan Alteration Associated with Renal Cell Carcinoma Detected by High Throughput Glycan Analysis

Shingo Hatakeyama, Maho Amano, Yuki Tobisawa, Tohru Yoneyama, Norihiko Tsuchiya, Tomonori Habuchi, Shin-Ichiro Nishimura, Chikara Ohyama

Journal of Urology   191 ( 3 )   805 - 813   2014年03月

Serum N-glycan profiling predicts prognosis in patients undergoing hemodialysis.

Shingo Hatakeyama, Maho Amano, Yuki Tobisawa, Tohru Yoneyama, Megumi Tsushima, Kazuko Hirose, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hisao Saitoh, Kanemitsu Yamaya, Tomihisa Funyu, Shin-Ichiro Nishimura, Chikara Ohyama

TheScientificWorldJournal   2013   268407 - 268407   2013年12月

Random Phage Display-Based Screening of Peptides that Bind to Botulinum Neurotoxin Binding Protein, Nontoxic Nonhemagglutinin.

Sagane Y, Miyata K, Kurihara S, Yoneyama T, Inui K, Miyashita SI, Hayashi S, Suzuki T, Niwa K, Watanabe T.

Current Microbiology   67 ( 2 )   188 - 192   2013年08月

Random phage display-based screening of peptides that bind to botulinum neurotoxin binding protein, nontoxic nonhemagglutinin.

Sagane Y, Miyata K, Kurihara S, Yoneyama T, Inui K, Miyashita S, Hayashi S, Suzuki T, Niwa K, Watanabe T

Current microbiology   67 ( 2 )   188 - 192   2013年08月

Blood group antigen-targeting peptide suppresses anti-blood group antibody binding to antigen in renal glomerular capillaries after ABO-incompatible blood reperfusion.

Yoneyama T, Hatakeyama S, Tobisawa Y, Yamamoto H, Imanishi K, Okamoto T, Tokui N, Sugiyama N, Suzuki Y, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Fukuda MN, Ohyama C

Transplantation   189 ( 4 )   E864 - E864   2013年04月

Blood group antigen-targeting peptide suppresses anti-blood group antibody binding to antigen in renal glomerular capillaries after ABO-incompatible blood reperfusion

Yoneyama Tohru, Hatakeyama S, Tobisawa Y, Yamamoto H, Imanishi K, Okamoto T, Tokui N, Sugiyama N, Suzuki Y, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Fukuda NM, Ohyama C

Transplantation   95 ( 3 )   2013年02月

SerumN-Glycan Profiling Predicts Prognosis in Patients Undergoing Hemodialysis

Shingo Hatakeyama, Maho Amano, Yuki Tobisawa, Tohru Yoneyama, Megumi Tsushima, Kazuko Hirose, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hisao Saitoh, Kanemitsu Yamaya, Tomihisa Funyu, Shin-Ichiro Nishimura, Chikara Ohyama

The Scientific World Journal   2013   1 - 10   2013年

Fer kinase regulates cell migration through α-dystroglycan glycosylation (共著)

Yoneyama T, Angata K, Bao X, Courtneidge S, Chanda S, & Fukuda M.

Molecular Biology of the cell   23 ( 5 )   771 - 780   2012年06月

Biochemical outcome of small-volume or insignificant prostate cancer treated with radical prostatectomy in Japanese population

HASHIMOTO Yasuhiro, OKAMOTO Akiko, IMAI Atsushi, YONEYAMA Tohru, HATAKEYAMA Shingo, YONEYAMA Takahiro, KOIE Takuya, KAMINURA Noritaka, OHYAMA Chikara

17 ( 2 )   119 - 123   2012年04月

Biochemical outcome of small-volume or insignificant prostate cancer treated with radical prostatectomy in Japanese population.

Hashimoto Y, Okamoto A, Imai A, Yoneyama T, Hatakeyama S, Yoneyama T, Koie T, Kaminura N, Ohyama C

International journal of clinical oncology   17 ( 2 )   119 - 123   2012年04月

Fer kinase regulates cell migration through α-dystroglycan glycosylation.

Yoneyama T, Angata K, Bao X, Courtneidge S, Chanda SK, Fukuda M, Molecular biology of

Molecular biology of the cell   23 ( 5 )   771 - 780   2012年03月

A Switch From Conventional Twice-Daily Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Kidney Transplant Recipients

S. Hatakeyama, T. Fujita, T. Yoneyama, T. Yoneyama, T. Koie, Y. Hashimoto, H. Saitoh, T. Funyu, S. Narumi, C. Ohyama

TRANSPLANTATION PROCEEDINGS   44 ( 1 )   121 - 123   2012年01月

Characterization of sugar recognition by the toxin complex produced by the Clostridium botulinum serotype C variant strain

Matsuo T, Miyata K, Inui K, Ito H, Horiuchi R, Suzuki T, Yoneyama T, Oguma K, Niwa K, Watanabe T & Ohyama T

FEMS Immunology and Medical Microbiology   63 ( 1 )   35 - 43   2011年10月

Characterization of sugar recognition by the toxin complex produced by the Clostridium botulinum serotype C variant strain Yoichi.

Matsuo T, Miyata K, Inui K, Ito H, Horiuchi R, Suzuki T, Yoneyama T, Oguma K, Niwa K, Watanabe T, Ohyama T

FEMS immunology and medical microbiology   63 ( 1 )   35 - 43   2011年10月

Biochemical outcome of small-volume or insignificant prostate cancer treated with radical prostatectomy in Japanese population.

Hashimoto Y, Okamoto A, Imai A, Yoneyama T, Hatakeyama S, Yoneyama T, Koie T, Kaminura N & Ohyama C

International Journal of Clinical Oncology   17 ( 2 )   119 - 123   2011年04月

PP-390 ABO血液型抗原をマスクするペプチド配列のスクリーニング(一般演題ポスター発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)

米山 徹, 畠山 真吾, 今西 賢吾, 得居 範子, 岡本 哲平, 杉山 尚樹, 鈴木 裕一朗, 工藤 茂将, 米山 高弘, 盛 和行, 古家 琢也, 神村 典孝, 大山 力

日本泌尿器科学会雑誌   102 ( 2 )   468   2011年

PP-038 ナノパーティクルBCGはBCG生菌無効の細胞株に対して直接効果を有する(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)

盛 和行, 米山 徹, 今西 賢悟, 得居 範子, 杉山 尚樹, 立和田 得志, 畠山 真吾, 工藤 茂将, 米山 高弘, 古家 琢也, 神村 典孝, 中川 昌之, 大山 力

日本泌尿器科学会雑誌   102 ( 2 )   409   2011年

OP-186 CRPCに対するDocetaxel,Prednisolone,Zoledronic acid療法の検討(前立腺腫瘍/薬物療法2,一般演題口演,第99回日本泌尿器科学会総会)

米山 高弘, 岡本 哲平, 得居 範子, 鈴木 裕一朗, 杉山 尚樹, 米山 徹, 畠山 真吾, 工藤 茂将, 盛 和行, 古家 琢也, 神村 典孝, 羽渕 友則, 大山 力

日本泌尿器科学会雑誌   102 ( 2 )   371   2011年

OP-156 限局性前立腺癌のブラキ治療後排尿障害に対するα1ブロッカーの効果について(前立腺腫瘍/放射線治療1,一般演題口演,第99回日本泌尿器科学会総会)

神村 典孝, 岡本 哲平, 得居 範子, 杉山 尚樹, 鈴木 裕一朗, 畠山 真吾, 工藤 茂将, 米山 高弘, 古家 琢也, 米山 徹, 盛 和行, 大山 力

日本泌尿器科学会雑誌   102 ( 2 )   366   2011年

APP-013 腎細胞癌における血清N-結合型糖鎖の網羅的解析による新規バイオマーカーの検索(総会賞応募ポスター,第99回日本泌尿器科学会総会)

畠山 真吾, 山本 隼人, 米山 徹, 盛 和行, 工藤 茂将, 米山 高弘, 古家 琢也, 神村 典孝, 對馬 惠, 舟生 富壽, 天野 麻穂, 西村 紳一郎, 大山 力

日本泌尿器科学会雑誌   102 ( 2 )   299   2011年

Identification of carbohydrate-binding proteins by carbohydrate mimicry peptides

Fukuda N M, Yoneyama T

Methods in Enzymology   478   563 - 572   2010年09月

Sialic acid-dependent binding and transcytosis of serotype D botulinum neurotoxin and toxin complex in rat intestinal epithelial cells

Niwa K, Yoneyama T, Ito H, Taira M, Chikai T, Kouguchi H, Suzuki T, Hasegawa K, Miyata, K, Inui, K, Ikeda T, Watanabe T, and Ohyama T

Veterinary Microbiology   141 ( 3-4 )   312 - 320   2010年03月

Sialic acid-dependent binding and transcytosis of serotype D botulinum neurotoxin and toxin complex in rat intestinal epithelial cells.

Niwa K, Yoneyama T, Ito H, Taira M, Chikai T, Kouguchi H, Suzuki T, Hasegawa K, Miyata K, Inui K, Ikeda T, Watanabe T, Ohyama T

Veterinary microbiology   141 ( 3-4 )   312 - 320   2010年03月

Identification of carbohydrate-binding proteins by carbohydrate mimicry peptides.

Fukuda MN, Yoneyama T

Methods in enzymology   478   563 - 572   2010年

Expression and stability of the nontoxic component of the botulinum toxin complex

Miyata K, Yoneyama T, Suzuki T, Kouguchi H, Inui K, Niwa K, Watanabe T and Ohyama T

Biochemical and Biophysical Research Communications   384 ( 1 )   126 - 130   2009年06月

Expression and stability of the nontoxic component of the botulinum toxin complex.

Miyata K, Yoneyama T, Suzuki T, Kouguchi H, Inui K, Niwa K, Watanabe T, Ohyama T

Biochemical and biophysical research communications   384 ( 1 )   126 - 130   2009年06月

Molecular characterization of the protease from Clostridium botulinum serotype C responsible for nicking in botulinum neurotoxin complex

Suzuki T, Yoneyama T, Miyata K, Mikami A, Chikai T, Inui K, Kouguchi H, Niwa K, Watanabe T, Miyazaki S and Ohyama T

Biochemical and Biophysical Research Communications   379 ( 2 )   309 - 313   2009年02月

Molecular characterization of the protease from Clostridium botulinum serotype C responsible for nicking in botulinum neurotoxin complex.

Suzuki T, Yoneyama T, Miyata K, Mikami A, Chikai T, Inui K, Kouguchi H, Niwa K, Watanabe T, Miyazaki S, Ohyama T

Biochemical and biophysical research communications   379 ( 2 )   309 - 313   2009年02月

Clostridium botulinum Serotype D neurotoxin and toxin complex bind to bovine aortic endothelial cells via sialic acid

Yoneyama T, Miyata, K, Chikai, T, Mikami, A, Suzuki, T, Hasegawa, K, Ikeda, T, Watanabe, T, Ohyama, T and Niwa, K

FEMS Immunology & Medical Microbiology   54 ( 3 )   290 - 298   2008年12月

Clostridium botulinum serotype D neurotoxin and toxin complex bind to bovine aortic endothelial cells via sialic acid（ボツリヌスD型神経毒素と毒素複合体のシアル酸を介したウシ血管内皮細胞への結合）

Yoneyama T, Miyata K, Chikai T, Mikami A, Suzuki T, Hasegawa K, Ikeda T, Watanabe T, Ohyama T, Niwa K

FEMS Immunology and Medical Microbiology   54   299 - 313   2008年12月

Clostridium botulinum serotype D neurotoxin and toxin complex bind to bovine aortic endothelial cells via sialic acid.

Yoneyama T, Miyata K, Chikai T, Mikami A, Suzuki T, Hasegawa K, Ikeda T, Watanabe T, Ohyama T, Niwa K

FEMS immunology and medical microbiology   54 ( 3 )   290 - 298   2008年12月

A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms

Hasegawa K, Watanabe T, Suzuki T, Yamano A, Oikawa T, Sato Y, Kouguchi H, Yoneyama T, Niwa K, Ikeda T, and Ohyama T

THE JOURNAL OF BIOLOGICAL CHEMISTRY   282 ( 34 )   24777 - 24783   2007年08月

A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms.

Hasegawa K, Watanabe T, Suzuki T, Yamano A, Oikawa T, Sato Y, Kouguchi H, Yoneyama T, Niwa K, Ikeda T, Ohyama T

The Journal of biological chemistry   282 ( 34 )   24777 - 24783   2007年08月

Expression and characterization of a recombinant unique acid phosphatase from kidney bean hypocotyl exhibiting chloroperoxidase activity in the yeast Pichia pastoris

Yoneyama T, Taira M, Suzuki T, Nakamura M, Niwa K, Watanabe T, and Ohyama T

Protein Expression and Purification   53 ( 1 )   31 - 39   2007年05月

Expression and characterization of a recombinant unique acid phosphatase from kidney bean hypocotyl exhibiting chloroperoxidase activity in the yeast Pichia pastoris.

Yoneyama T, Taira M, Suzuki T, Nakamura M, Niwa K, Watanabe T, Ohyama T

Protein expression and purification   53 ( 1 )   31 - 39   2007年05月

Effect of nicking the C-terminal region of the Clostridium botulinum serotype D neurotoxin heavy chain on its toxicity and molecular properties.

Suzuki T, Kouguchi H, Watanabe T, Hasegawa K, Yoneyama T, Niwa K, Nishikawa A, Lee J-C, and Ohyama T

The Protein Journal   26 ( 3 )   173 - 181   2007年04月

Effect of nicking the C-terminal region of the Clostridium botulinum serotype D neurotoxin heavy chain on its toxicity and molecular properties.

Suzuki T, Kouguchi H, Watanabe T, Hasegawa K, Yoneyama T, Niwa K, Nishikawa A, Lee JC, Oguma K, Ohyama T

The protein journal   26 ( 3 )   173 - 181   2007年04月

Study on kidney bean hypocotyls specific acid phosphatase exhiubiting vanadate-dependent chloroperoxidase activity

Yoneyama T, Shiozawa M, Nakamura M, Suzuki T, Sagane Y, Katoh Y, Watanabe T, Ohyama T.

J Biol Chem.   279 ( 36 )   37477 - 37488   2007年03月

Quantitative detection of gene expression and toxin complex produced by Clostridium botulinum serotype D strain 4947

Kouguchi, H, Suzuki, T, Hasegawa, K, Mutoh, S, Watanabe, T, Niwa, K, Yoneyama T, Katoh Y, and Ohyama T

Journal of Microbiological Methods   67 ( 3 )   416 - 423   2006年12月

Quantitative detection of gene expression and toxin complex produced by Clostridium botulinum serotype D strain 4947.

Kouguchi H, Suzuki T, Hasegawa K, Mutoh S, Watanabe T, Niwa K, Yoneyama T, Katoh Y, Ohyama T

Journal of microbiological methods   67 ( 3 )   416 - 423   2006年12月

Characterization of a novel acid phosphatase from embryonic axes of kidney bean exhibiting vanadate-dependent chloroperoxidase activity

Yoneyama T, Shiozawa M, Nakamura M, Suzuki T, Sagane Y, Katoh Y, Watanabe T, and Ohyama T

THE JOURNAL OF BIOLOGICAL CHEMISTRY   279 ( 36 )   37477 - 37484   2004年09月

Characterization of a novel acid phosphatase from embryonic axes of kidney bean exhibiting vanadate-dependent chloroperoxidase activity.

Yoneyama T, Shiozawa M, Nakamura M, Suzuki T, Sagane Y, Katoh Y, Watanabe T, Ohyama T

The Journal of biological chemistry   279 ( 36 )   37477 - 37484   2004年09月

グライコミクスによる新規疾患バイオマーカーの探索

米山　徹、大山　力（ 担当： 共著）

一般社団法人 日本臨床科学会  2015年7月 

ABO血液型抗原をマスクするペプチド配列のスクリーニング 第44回日本臨床腎移植学会記録集 臨床腎移植症例集2011

米山　徹、畠山真吾、今西賢吾、得居範子、岡本哲平、杉山尚樹、鈴木裕一朗、工藤茂将、米山高弘、盛　和行、古家琢也、神村典孝、大山　力（ 担当： 共著）

日本医学館  2011年10月 

遠隔転移を有しない去勢抵抗性前立腺癌(M0CRPC)に対しダロルタミド投与後ロボット支援前立腺全摘(RARP)を施行した1例

富樫赳, 岡本哲平, 米山徹, 山本勇人, 畠山真吾, 米山高弘, 橋本安弘, 大山力

泌尿器外科   36 ( 10 )   1158 - 1159   2023年

MRI/US画像融合ガイド下前立腺生検におけるProstate Lesion Volumeの検討

山本勇人, 濱谷智子, 富樫赳, 相馬理, 藤田尚紀, 岡本哲平, 畠山真吾, 米山徹, 米山高弘, 橋本安弘

日本泌尿器内視鏡・ロボティクス学会(Web)   37th   P - 11   2023年

イムノグロブリンN型糖鎖プロファイルを基盤とした機械学習アプローチによる腎移植後の拒絶予測モデルの開発

小玉寛健, 米山徹, 岩村大径, 藤田尚紀, 田中壽和, 畠山真吾, 柿崎育子, 大山力

日本移植学会総会プログラム抄録集   59th (Web) ( 総会臨時 )   226 - 226   2023年

肉腫成分を伴った転移性腎細胞癌の1例

濱谷智子, 畠山真吾, 米山徹, 吉澤忠司, 大鹿周佐, 佐々木大地, 相馬理, 奥山佐治, 岡本哲平, 山本勇人, 米山高弘, 橋本安弘, 大山力

泌尿器外科   36 ( 10 )   1159 - 1159   2023年

筋層浸潤性膀胱癌に対する術前化学療法によりPDL1発現は誘導されるか?

佐々木大地, 畠山真吾, 三浦佑規, 尾崎佑輔, 尾崎魁, 米山徹, 米山高弘, 橋本安弘, 大山力

泌尿器科分子・細胞研究会プログラム・抄録集   32nd   2023年

全自動蛍光免疫測定装置ミュータスワコーi50によるS2,3PSA%測定試薬の基本性能評価

米山徹, 鈴木啓, 大坪拓真, 大山力

医療と検査機器・試薬   46 ( 5 )   244 - 257   2023年

尿意切迫感と眼瞼下垂の関係 岩木町健康増進プロジェクトの結果から

尾崎 佑輔, 岡本 哲平, 畠山 真吾, 米山 徹, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力, 中路 重之, 三浦 佑規

泌尿器外科   35 ( 臨増 )   838 - 838   2022年7月

腎結石形成に関与する糖鎖変異オステオポンチンの探索

阿南 剛, 米山 徹, 廣瀬 卓男, 畠山 真吾, 森 建文, 大山 力, 佐藤 信

日本尿路結石症学会誌   21 ( 1 )   49 - 49   2022年7月

【デジタル革命が導く遠隔医療とAI】Deep learningによる転移性前立腺がんのCRPC進展予測とその問題点

畠山 真吾, 米山 徹, 岡本 哲平, 成田 拓磨, 岩村 大径, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力

泌尿器科   15 ( 6 )   646 - 652   2022年6月

ロボット支援前立腺全摘術後患者におけるフレイルとQOLおよび下部尿路症状の関連性についての検討(FRARP-QL Study)

富樫 赳, 畠山 真吾, 岩村 大径, 小島 由太, 岡本 哲平, 米山 徹, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力

日本老年泌尿器科学会誌   35 ( 1 )   160 - 160   2022年5月

腎移植レシピエントに対するコロナワクチン接種後の血清陽性率の検討

濱谷 智子, 畠山 真吾, 米山 徹, 小玉 寛健, 藤田 雄, 村上 礼一, 鳴海 俊治, 大山 力

日本透析医学会雑誌   55 ( Suppl.1 )   677 - 677   2022年5月

限局性前立腺癌患者に対するロボット支援腹腔鏡下根治的前立腺全摘除術におけるフレイルと術後疼痛との関連

相馬 理, 畠山 真吾, 百田 匡毅, 岡本 哲平, 米山 徹, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力

日本老年泌尿器科学会誌   35 ( 1 )   106 - 106   2022年5月

【泌尿器科の未来を拓く基礎研究】新規ヒアルロン酸分解酵素transmembrane protein2(TMEM2)の機能

山本 勇人, 藤田 尚紀, 飛澤 悠葵, 米山 美穂子, 米山 徹, 畠山 真吾, 大山 力

泌尿器科   15 ( 4 )   375 - 382   2022年4月

免疫チェックポイント阻害剤に対してMixed responseを呈し小腸転移を生じた進行性腎癌の一例

小玉 寛健, 畠山 真吾, 富樫 赳, 堀口 裕貴, 成田 拓磨, 岩村 大径, 小島 由太, 岡本 哲平, 米山 徹, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力, 鬼島 宏, 後藤 慎太郎

泌尿器外科   35 ( 4 )   356 - 356   2022年4月

乳腺葉状腫瘍と酷似する組織を伴った膀胱癌の1例

濱野 逸人, 畠山 真吾, 米山 美穂子, 濱谷 智子, 百田 匡毅, 成田 拓磨, 小島 由太, 岩村 大径, 岡本 哲平, 米山 徹, 山本 勇人, 米山 高弘, 橋本 安弘, 黒瀬 顕, 大山 力

泌尿器外科   35 ( 4 )   353 - 354   2022年4月

【泌尿器科の未来を拓く基礎研究】次世代高精度放射線治療 分子標的ホウ素中性子捕捉療法の開発

米山 徹, 畠山 真吾, 米山 美穂子, 飛澤 悠葵, 野中 元裕, 鈴木 実, 八戸 慎吾, 大山 力

泌尿器科   15 ( 4 )   351 - 359   2022年4月

左腎に晩期再発をきたした卵巣顆粒膜細胞腫の一例

富樫 赳, 橋本 安弘, 堀口 裕貴, 小玉 寛健, 成田 拓磨, 小島 由太, 岩村 大径, 岡本 哲平, 米山 徹, 山本 勇人, 畠山 真吾, 米山 高弘, 大山 力

泌尿器外科   35 ( 4 )   355 - 356   2022年4月

術前化学療法抵抗性のSarcomatiod variantを伴う筋層浸潤性膀胱癌に対しペンブロリズマブで病理学的完全奏功した一例

尾崎 佑輔, 岡本 哲平, 小西 栄, 小玉 寛健, 堀口 裕貴, 岩村 大径, 小島 由太, 成田 拓磨, 飛澤 悠葵, 米山 徹, 盛 和行, 山本 勇人, 畠山 真吾, 米山 高弘, 橋本 安弘, 大山 力

泌尿器外科   35 ( 4 )   360 - 360   2022年4月

CRPCにおけるリキッドバイオプシー 糖鎖とcfDNAを用いた検討

畠山 真吾, 米山 徹, 濱野 逸人, 久保田 優花, 松本 哲平, 成田 拓磨, 藤田 尚紀, 岡本 哲平, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力

泌尿器科   15 ( 1 )   83 - 91   2022年1月

Oligomets前立腺がんの診断としてのLiquid biopsyの現状:画像診断との併用で何が変わるか

畠山真吾, 米山徹, 大山力

日本泌尿器科学会東部総会プログラム・抄録集   87th   2022年

ステロイドを併用している前立腺癌患者はSARS-CoV-2mRNAワクチンに対する免疫反応は弱いのか?

石井伯昂, 畠山真吾, 米山徹, 田中龍馬, 成田琢磨, 藤田尚紀, 岡本哲平, 山本勇人, 米山高弘, 橋本安弘, 大山力

日本泌尿器科学会東部総会プログラム・抄録集   87th ( 臨増 )   867 - 867   2022年

当科における腎移植レシピエントのmRNAコロナワクチン2回目接種後の抗体価

濱谷智子, 畠山真吾, 米山徹, 飛澤悠葵, 小玉寛健, 藤田雄, 村上礼一, 岡本哲平, 山本勇人, 米山高弘, 橋本安弘, 齋藤久夫, 鳴海俊治, 富田泰史, 大山力, 大山力, 大山力

日本泌尿器科学会東部総会プログラム・抄録集   87th ( 臨増 )   859 - 859   2022年

尿路結石形成の解明と治療への応用を目指して

畠山真吾, 米山徹

日本泌尿器科学会東部総会プログラム・抄録集   87th   2022年

前立腺癌の新規診断マーカーS2,3PSA%の臨床有用性と今後の展望

米山徹, 大山力

臨床化学(Web)   51   2022年

ディープ・ラーニングを用いた転移性前立腺癌のCRPC進展予測とその問題点

三浦佑規, 畠山真吾, 米山徹, 岡本哲平, 成田拓磨, 岩村大径, 山本勇人, 米山高弘, 橋本安弘, 大山力, 大山力, 大山力

日本泌尿器科学会東部総会プログラム・抄録集   87th ( 臨増 )   846 - 846   2022年

Cell-free DNA(cfDNA)を測定した去勢抵抗性前立腺癌(CRPC)の1例

濱野 逸人, 畠山 真吾, 米山 徹, 鈴木 裕一朗, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 大山 力

泌尿器外科   34 ( 11 )   1296 - 1296   2021年11月

Whole Body MRIにて病勢評価が可能であった去勢抵抗性前立腺癌(CRPC)の1例

細越 正吾, 畠山 真吾, 米山 徹, 米山 高弘, 橋本 安弘, 大山 力

泌尿器外科   34 ( 11 )   1288 - 1288   2021年11月

難治性間質性膀胱炎・膀胱痛症候群患者の1例

久保田 優花, 濱野 逸人, 米山 徹, 山本 勇人, 今井 篤, 畠山 真吾, 米山 高弘, 橋本 安弘, 大山 力

泌尿器外科   34 ( 11 )   1296 - 1296   2021年11月

【日本発の臨床研究からみた前立腺癌診療】前立腺癌の診断、悪性度評価に関する日本発のPSA糖鎖変異バイオマーカー

米山 徹, 金子 智典, 彼谷 高敏, 米山 美穂子, 飛澤 悠葵, 畠山 真吾, 大山 力

Prostate Journal   8 ( 2 )   194 - 203   2021年10月

尿路結石形成に関与する糖鎖変異オステオポンチンの検索

阿南 剛, 米山 徹, 野呂 大輔, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力

日本内分泌学会雑誌   97 ( Suppl.Update )   47 - 49   2021年7月

前立腺癌患者におけるフレイルとQOLの関係(FRAQ-PC study)

濱谷 智子, 畠山 真吾, 大山 力, 橋本 安弘, 米山 高弘, 今井 篤, 山本 勇人, 米山 徹, 岡本 哲平, 藤田 尚紀, 濱野 逸人, 小島 由太, 岩村 大径, 成田 拓磨, 百田 匡毅

泌尿器外科   34 ( 臨増 )   799 - 799   2021年6月

尿路結石形成に関与する糖鎖変異オステオポンチンの検索

阿南 剛, 米山 徹, 野呂 大輔, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 伊藤 淳, 海法 康裕, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力

泌尿器科紀要   67 ( 6 )   272 - 272   2021年6月

前立腺癌患者の治療選択とG8スコアの関連性についての検討

富樫 赳, 畠山 真吾, 百田 匡毅, 相馬 理, 田中 壽和, 濱野 逸人, 藤田 尚紀, 岡本 哲平, 米山 徹, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 大山 力

泌尿器外科   34 ( 臨増 )   799 - 799   2021年6月

臨床化学に寄与する糖鎖科学の進展 前立腺癌の過剰診断・過剰治療を回避するPSA糖鎖変異マーカー

米山 徹, 金子 智典, 彼谷 高敏, 石川 友一, 米山 美穂子, 畠山 真吾, 大山 力

日本臨床検査医学会誌   69 ( 6 )   441 - 449   2021年6月

腎臓結石形成に関与する糖鎖変異オステオポンチンの同定

阿南 剛, 米山 徹, 畠山 真吾, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力

日本腎臓学会誌   63 ( 4 )   447 - 447   2021年6月

血管内皮細胞を標的としたがん特異的療法の開発

畠山 真吾, 米山 徹, 大山 力

細胞   53 ( 2 )   99 - 103   2021年2月

高リスク上部尿路上皮癌における術前化学療法と腫瘍学的転帰の傾向:多施設後ろ向き研究

濱谷智子, 畠山真吾, 田中壽和, 久保田優花, 富樫赳, 細越正吾, 得居範子, 松本哲平, 山本勇人, 米山徹, 米山高弘, 橋本安弘, 大山力, 大山力, 大山力

日本泌尿器科学会総会(Web)   109th   PP25 - 02   2021年

腎臓結石形成に関与する糖鎖変異オステオポンチンの同定

阿南剛, 米山徹, 畠山真吾, 米山高弘, 橋本安弘, 佐藤信, 大山力

日本腎臓学会誌(Web)   63 ( 4 )   2021年

去勢抵抗性前立腺癌におけるCell-free DNAの有効性

久保田優花, 畠山真吾, 米山徹, 米山美穂子, 山本勇人, 米山高弘, 橋本安弘, 大山力

日本泌尿器科学会総会(Web)   109th   AOP10 - 07   2021年

網羅的血清糖鎖分析による生体腎移植後拒絶反応予測マーカーの開発

小玉寛健, 米山徹, 相馬理, 野呂大輔, 山本勇人, 畠山真吾, 米山高弘, 橋本安弘, 大山力

日本泌尿器科学会東部総会プログラム・抄録集   86th   2021年

筋層浸潤膀胱癌の治療選択における定量的フレイル評価の有用性(FRART-BC study)

岩村大径, 畠山真吾, 百田匡毅, 小島由太, 成田琢磨, 岡本哲平, 濱野逸人, 濱谷智子, 米山徹, 山本勇人, 米山高弘, 橋本安弘, 大山力

日本泌尿器科学会総会(Web)   109th   PP05 - 02   2021年

筋層浸潤性膀胱に対する術前化学療法+膀胱全摘術後のKi67とPD-1発現の意義

堀口裕貴, 畠山真吾, 久保田優花, 米山徹, 米山高弘, 橋本安弘, 大山力

日本泌尿器科学会総会(Web)   109th   PP27 - 03   2021年

ハイリスク前立腺癌に対する術前内分泌化学療法+ロボット支援前立腺全摘術の治療成績

米山 高弘, 堀口 裕貴, 百田 匡毅, 久保田 優花, 濱野 逸人, 鈴木 裕一朗, 米山 徹, 山本 勇人, 盛 和行, 今井 篤, 畠山 真吾, 橋本 安弘, 大山 力

日本泌尿器科学会総会   108回   1478 - 1478   2020年12月

腫瘍血管内皮を標的にした新規ホウ素中性子捕捉療法による膀胱癌治療法の開発

畠山 真吾, 米山 徹, 米山 美穂子, 山本 勇人, 米山 高弘, 橋本 安弘, 石山 新太郎, 鈴木 実, 大山 力

日本泌尿器科学会総会   108回   885 - 885   2020年12月

尿路上皮癌の治療前QOLが予後に与える影響についての検討

村澤 洋美, 畠山 真吾, Sappaya Suppanuntaroek, 米山 徹, 米山 高弘, 橋本 安弘, 大山 力

日本泌尿器科学会総会   108回   1703 - 1703   2020年12月

前立腺癌患者のフレイルに関するG8スコアの有用性

百田 匡毅, 畠山 真吾, 相馬 理, 田中 壽和, 濱野 逸人, 藤田 尚紀, 岡本 哲平, 米山 徹, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 大山 力

日本泌尿器科学会総会   108回   1460 - 1460   2020年12月

マージナルドナーからの生体腎移植における移植成績ならびにドナー・レシピエント腎機能の検討

濱野 逸人, 畠山 真吾, 濱谷 智子, 百田 匡毅, 成田 拓磨, 小島 由太, 岩村 大径, 米山 徹, 岡本 哲平, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力

移植   55 ( 総会臨時 )   356 - 356   2020年10月

当科におけるABO不適合移植の移植成績

濱谷 智子, 濱野 逸人, 畠山 真吾, 藤田 雄, 村上 礼一, 岡本 哲平, 鈴木 裕一朗, 山本 勇人, 米山 徹, 米山 高弘, 橋本 安弘, 齋藤 久夫, 鈴木 唯司, 大山 力

移植   55 ( 総会臨時 )   360 - 360   2020年10月

臨床化学に寄与する糖鎖科学の進展 前立腺癌の過剰診断・過剰治療を回避するPSA糖鎖変異マーカー

米山 徹, 金子 智典, 彼谷 高敏, 石川 友一, 米山 美穂子, 畠山 真吾, 大山 力

臨床病理   68 ( 補冊 )   085 - 085   2020年10月

Survey on attitudes toward brain-dead and living donor transplantation in medical students: a cross-sectional study in Japan.

Hamano I, Hatakeyama S, Yamamoto H, Fujita T, Murakami R, Shimada M, Imai A, Yoneyama T, Yoneyama T, Hashimoto Y, Saitoh H, Suzuki T, Tomita H, Ohyama C

Clinical and experimental nephrology   24 ( 7 )   638 - 645   2020年7月

Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy.

Kodama H, Koie T, Oikawa M, Narita T, Tanaka T, Noro D, Iwamura H, Tobisawa Y, Yoneyama T, Hashimoto Y, Ohyama C

International urology and nephrology   52 ( 4 )   671 - 679   2020年4月

STone Episode Prediction: Development and validation of the prediction nomogram for urolithiasis.

Okita K, Hatakeyama S, Imai A, Tanaka T, Hamano I, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Nakaji S, Suzuki T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   27 ( 4 )   344 - 349   2020年4月

前立腺がんの過剰診断・過剰治療を回避する糖鎖関連バイオマーカー

米山 徹, 飛澤 悠葵, 畠山 真吾, 石川 友一, 金子 智典, 彼谷 高敏, 大山 力

泌尿器科   11 ( 1 )   99 - 110   2020年1月

フレイルがロボット支援下腹腔鏡下根治的前立腺切除術後の疼痛に与える影響

百田匡毅, 畠山真吾, 畠山真吾, 相馬理, 濱野逸人, 藤田尚樹, 岡本哲平, 米山徹, 山本勇人, 橋本安弘, 大山力, 大山力

日本老年泌尿器科学会誌   33 ( 1 )   117 - 117   2020年

筋層浸潤膀胱癌の治療選択における定量的フレイル評価の有用性

岩村大径, 畠山真吾, 百田匡毅, 小島由太, 成田琢磨, 岡本哲平, 藤田尚紀, 濱野逸人, 富樫赳, 濱谷智子, 米山徹, 山本勇人, 米山高弘, 橋本安弘, 大山力

日本癌治療学会学術集会(Web)   58th   P - 336   2020年